IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

Office of Directorate General of Foreign Trade New Delhi -0

------------------------------------------------------------------------------

Para 4.7 Decision

Minutes of the Meeting No. 15/82-ALC4/2018 dated 22.03.2019 (actually held on 29.03.2019, 11.04.2019, 18.04.2019, 26.04.2019 and 02.05.2019) for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30, held under the Chairmanship of Shri Satyan Sharda, Addl. DGFT in Room No.11, Udyog Bhawan, New Delhi.

Following members were present:-

(i) Shri Nirmal Kumar, Dy. Director General of Foreign Trade (ii) Shri S.K. Panigrahi, Economic Officer (iii) Shri Ajay Kumar, Assistant Director (iv) Consultant, Technical Expert Pharmaceuticals (v) Consultant, Technical Expert Chemicals

The committee went through the minutes of earlier meeting No. 14/82-ALC4/2018 dated 14.02.2019 (actually held on 22.02.2019, 28.02.2019, 08.03.2019 and 12.03.2019) and approved the same.

MEETING NUMBER : 15/82-ALC4/2018 MEETING DATE :22.03.2019 (actually held on 29.03.2019, 11.04.2019, 18.04.2019, 26.04.2019 and 02.05.2019)

ONLINE CASES (UPTO 500 CASES)

Case No.:183/33/82-	Party Name:S.M. HERBALS	Meet No/Date:15/82-	Status:
ALC4/2012	PVT.LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510342102	Defer Date:
:01/82/050/01330/AM13/	:05/24/040/00366/AM13/	01.01.2013

Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 9/82-ALC4/2014 dated 20.10.2014, it was decided to ratify norms under Para 4.7 of HBP v1 as 1 per details given below or as applied by the firm, whichever is less:

	Export Product	Qty.	S.	Import Item	Qty.
			No.
	10- Deacetyl Baccatin - III	1 kg	1.	Ketones in Carbonyl group 10-	1.03 kg
	HPLC Purity NLT 98.5%			Deacetyl Baccatin - III
				HPLC NLT95%
RA maytake appropriate action asper the decision of Norms Committee.

Case No.:16/19/87-ALC1/2013	Party Name:S.KANT	Meet No/Date:15/82-	Status:
	HEALTHCARE LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310734894	Defer Date:
:01/87/050/00156/AM14/	:03/95/040/00707/AM13/	20.05.2013

---|---|---| |||HEALTHCARE LTD.||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0310734894||Defer Date:| |:01/87/050/00156/AM14/||:03/95/040/00707/AM13/||20.05.2013|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015 dated 25.06.2015, 10/82-ALC4/2018 dated 16.10.2018 and 11/82-ALC4/2014 dated 26.11.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per 2 details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
DI HYDRO ARTEMISININ	1 kg	1	ARTEMISININ	1.00 kg
ARTESUNATE	1 kg	1	ARTEMISININ	0.889 kg
ARTEMETHER	1 kg	1	ARTEMISININ	1.04 kg

RA concerned may take further necessary action as per above decision of NC.

Case No.:78/15/82-ALC4/2018	Party Name:AMI ORGANICS	Meet No/Date:15/82-	Status:
	PVT LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:5210041428	Defer Date:
:01/82/050/01535/AM19/	:52/24/040/00058/AM15/	13.02.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 9/82-ALC4/2018, dated 18.09.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 3 applied by firm whichever is lower:

ts Meeting No. 9/82-ALC4/2018, dated 18.09.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 3 applied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
1,(3 CL PHENYL)-4-(3-CL<br>PHENYL) PIPERAZINE HCL -<br>99% MIN.	1 kg	1	1,3-BROMO CHLORO PROPANE<br>99.5% MIN.	0.924 kg

Case No.:40/8/82-ALC4/2015	Party Name:SYNTHO	Meet No/Date:15/82-	Status:
	CHIRALS PVT. LTD	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910061937	Defer Date:
:01/82/050/00836/AM16/	:09/24/040/00042/AM16/	27.04.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 6/82-ALC4/2018, dated 26.07.2018, it was 4 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product<br>O-3,4,5-trifluorophenyl<br>chlorothioformate	Qty.	Sl. No.	Import items	Qty.
	1 Kg.	1.	3, 4, 5-TRIFLUOROPHENOL	0.846 kg

Case No.:239/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Withdrawn
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510394123	Defer Date:
:01/82/050/01696/AM19/	:05/24/040/00029/AM16/	07.05.2015

ALC4/2018**||SOLVENTS LTD.,||ALC4/2018||Withdrawn| ||||||22.03.2019||| ||HQ File||RLA File||Lic.No/Date:0510394123||Defer Date:| ||:01/82/050/01696/AM19/||:05/24/040/00029/AM16/||07.05.2015|||

5 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

The Committee considered the above e-mail and decided to Withdraw the case.

Case No.:945/15/82-	Party Name:BDR	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICALS	ALC4/2018	Approved
	INTERNATIONAL PVT. LTD.	22.03.2019
HQ File	RLA File	Lic.No/Date:0310795880	Defer Date:
:01/82/050/02402/AM19/	:03/94/040/00023/AM16/	13.05.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 2/82-ALC4/2015, dated 29.04.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 6 applied by firm whichever is lower:

Qty.	Import item	Qty.
Vial<br>up<br>to<br>10ml	Colistimethate Sodium for Injection<br>BP	96.65mg

BP Vol. I as per details below or as 6 applied by firm whichever is lower:

Qty.	Import item	Qty.
Vial<br>up<br>to<br>10ml	Colistimethate Sodium for Injection<br>BP	96.65mg

7	Case No.:943/15/82-<br>ALC4/2018	Party Name:NEW ALLIANCE<br>DYE-CHEM PVT. LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	HQ File<br>:01/82/050/02400/AM19/	RLA File<br>:03/95/040/00028/AM16/	Lic.No/Date:0310795908<br>14.05.2015	Defer Date:
	Decision:RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard<br>application of subject Advance Authorization. Application awaited from RLA,Mumbai.			copy of 4.07

Case No.:944/15/82-	Party Name:MANGALAM	Meet No/Date:15/82-	Status:
ALC4/2018	DRUGS & ORGANICS	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0310796147	Defer Date:
:01/82/050/02401/AM19/	:03/95/040/00108/AM16/	22.05.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was 8 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product<br>TENOFOVIR<br>DISOPROXIL<br>FUMARATE	Qty.	Sl.<br>No.	Import items	Qty.
	<br>1 kg	1	9-(2-(PHOSPHONYL METHOXY)<br>PROPYL)ADENINE(PMPA)	0.769 kg

s lower:

Export product<br>TENOFOVIR<br>DISOPROXIL<br>FUMARATE	Qty.	Sl.<br>No.	Import items	Qty.
	<br>1 kg	1	9-(2-(PHOSPHONYL METHOXY)<br>PROPYL)ADENINE(PMPA)	0.769 kg

Case No.:946/15/82-	Party Name:KARNATAKA	Meet No/Date:15/82-	Status:
ALC4/2018	ANTIBIOTICS &	ALC4/2018	Approved
	PHARMACEUTICALS LTD.,	22.03.2019
HQ File	RLA File	Lic.No/Date:0710108273	Defer Date:
:01/82/050/02403/AM19/	:07/24/040/00047/AM16/	27.05.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
CO-AMOXICLAV<br>1.20GM<br>INJ (VERCLAV 1.2GM INJ<br>VIAL SIZE: 20 ML) EACH<br>VIAL<br>CONTAINS:<br>POTASSIUM<br>CLAVULANATE<br>BP<br>EQUIVALENT<br>TO<br>CLAVULANATE<br>ACID<br>200MG<br>+<br>AMOXICILLIN<br>SODIUM BP EQUIVALENT<br>TO AMOXICILLIN 1 GM	<br> <br>1 Number	1	AMOXICILLIN SODIUM<br>WITH<br>POTASSIUM<br>CLAVULANATE<br>MIXTURE<br>(5<br>:<br>1)<br>STERILE BP (640.00 KGA)	<br>1320 mg / vial

Case No.:947/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710108278	Defer Date:
:01/82/050/02404/AM19/	:07/24/040/00042/AM16/	27.05.2015

	Case No.:947/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved<br> <br>Defer Date:
	HQ File<br>:01/82/050/02404/AM19/	RLA File<br>:07/24/040/00042/AM16/	Lic.No/Date:0710108278<br>27.05.2015
10	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in the<br>light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to<br>ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm<br>whichever is lower:<br>Export product<br>Qty.<br>Sl.No.<br>Import items<br>Qty.<br>Neulin 125mg Tablets -<br>Theophylline 125 Mg<br>+Guar gum 4.375 Mg<br>(9142857 No. of Tabs)<br>(Theop-1142.857<br>+GUAR.GUM 40.000<br>KGS)<br>1 no.

oduct Qty. Sl.No. Import items Qty. Neulin 125mg Tablets - Theophylline 125 Mg +Guar gum 4.375 Mg (9142857 No. of Tabs) (Theop-1142.857 +GUAR.GUM 40.000 KGS) 1 no. of Neulin Tablet 1. Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 127.5 mg 2. Guar Gum IH (BP / EP / USP / PH.EUR) 4.375 mg Neulin 200mg Tablets - Theophylline 200 Mg + Guar gum 7.00 Mg(9142857 No. of Tabs) (Theop- 1828.571+GUAR.GUM 64.000 KGS) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 204.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 7.00 mg Neulin 250mg Tablets - Theophylline 250 Mg + Guar gum 8.750 Mg (9142857 No. of Tabs) (Theop- 2285.714+GUAR.GUM 80.000 KGS) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 255.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 8.75 mg Neulin 300mg Tablets - Theophylline 300 Mg + Guar gum 10.5 Mg (9142857 No. of Tabs) (Theop- 2742.857+GUAR.GUM 96.000 KGS) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 306.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||||

P / EP / USP / PH.EUR Anhydrous Powder 306.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||||

11	<br>Case No.:948/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,<br>RLA File<br>:07/24/040/00043/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0710108280<br>27.05.2015	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/02405/AM19/
	Decision:Application received from RLA,Bangalore. Deferred for comments of TE.

12	<br>Case No.:1063/15/82-<br>ALC4/2018	Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02520/AM19/	RLA File<br>:04/24/040/00046/AM16/	Lic.No/Date:0410160592<br>27.05.2015	Defer Date:
	Decision:RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Chennai.

Case No.:949/15/82-	Party Name:DR REDDYS	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910062129	Defer Date:
:01/82/050/02406/AM19/	:09/24/040/00036/AM16/	03.06.2015

C4/2018**||LABORATORIES LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0910062129||Defer Date:| |:01/82/050/02406/AM19/||:09/24/040/00036/AM16/||03.06.2015|||

	Case No.:949/15/82-<br>ALC4/2018	Party Name:DR REDDYS<br>LABORATORIES LIMITED<br>RLA File<br>:09/24/040/00036/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0910062129<br>03.06.2015	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/02406/AM19/
13	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018, dated 16.10.2018, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Gemcitabine Hcl<br>1 kg<br>1<br>N-Acetyl Cytosine<br>2.92 kg<br>2<br>Trimethylsilyl Trifluoromethane sulfonate<br>(Or)<br>TrimethylsilylfluoromethaneSulphonate<br>4.23 kg<br>3<br>Dibenzoyllactol(or)DBL<br>4.78 kg<br>4<br>Methylene Chloride<br>13.60 kg<br>5<br>Methanol<br>8.80 kg<br>6<br>Acetone<br>15.00 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

tol(or)DBL 4.78 kg 4 Methylene Chloride 13.60 kg 5 Methanol 8.80 kg 6 Acetone 15.00 kg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018, dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

14	<br>Case No.:950/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,<br> <br> <br> <br>RLA File<br>:07/24/040/00065/AM16/<br> <br>	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br> <br><br>Lic.No/Date:0710108316<br>04.06.2015<br>	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02407/AM19/			Defer Date:
	Decision:Application received from RLA,Bangalore. Deferred for comments of TE.

	Case No.:1060/15/82-	Party Name:ARUDAA VIS		Meet No/Date:15/82-	Status:
	ALC4/2018	LABS PRIVATE LIMITED		ALC4/2018	Deferred
				22.03.2019
15	HQ File	RLA File		Lic.No/Date:0410160657	Defer Date:
	:01/82/050/02517/AM19/	:04/24/040/00015/AM16/		10.06.2015
	Decision:RLA, Chennai was requested vide e-mail dated		05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Chennai.

n:**RLA, Chennai was requested vide e-mail dated|||05.04.2019 to furnish the hard copy of 4.07||||| |||application of subject Advance Authorization. Application awaited from RLA,Chennai.||||||||

Decision: RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Chennai.

Case No.:951/15/82-	Party Name:OTSUKA	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICAL ( INDIA )	ALC4/2018	Withdrawn
	PRIVATE LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0510394527	Defer Date:
:01/82/050/02408/AM19/	:05/24/040/00063/AM16/	11.06.2015

16 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 11/82-ALC4.2014 dated 26.11.2014 .

The Committee considered the above e-mail and decided to withdraw the case.

Case No.:952/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710108355	Defer Date:
:01/82/050/02409/AM19/	:07/24/040/00070/AM16/	11.06.2015

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710108355||Defer Date:| |:01/82/050/02409/AM19/||:07/24/040/00070/AM16/||11.06.2015|||


	Case No.:952/15/82-<br>ALC4/2018<br> <br>	Party Name:ADCOCK<br>NGRAM LTD,			M<br>A	eet No/Date:15/82-<br>C4/2018	Sta<br>A	tus:<br>proved
	<br> <br>H Fil<br>				<br>22<br>Li	<br>.03.2019<br>N/D0710108355	p
		LA Fil					D	D
	Q e<br>:01/82/050/02409/AM19/<br> <br>:	e<br>07/24/040/00070/AM16/			c.oate:<br>11.06.2015		eer ate:
	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015 it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.
		Qty.	Sl.<br>No.	Import items			Qty.
	Neulin 125mg Tablets -<br>
		1 no. of<br>	1.	Theophylline BP / EP / USP /<br>PHEUR Ahd Pd			127.5 mg
17	(Theophylline 125 Mg<br>+Guar gum 4.375 Mg)<br>(9142857 No. of Tabs.)<br>	Neulin Tablet		.		nyrous ower
			2.	Guar G<br>PH.EU		um IH (BP / EP / USP /<br>R)	4	.375 mg
	(Theop-1142.857<br>+GUAR.GUM 40.000<br>
	KGS)<br>Neulin 200mg Tablets -<br>(Theophylline 200 Mg +<br>Guar gum 7.00 Mg)<br>(9142857 No.

G PH.EU||um IH (BP / EP / USP / R)|4|.375 mg|| ||(Theop-1142.857 +GUAR.GUM 40.000 ||||||||| ||KGS) Neulin 200mg Tablets - (Theophylline 200 Mg + Guar gum 7.00 Mg) (9142857 No. of Tabs) (Theop- 1828.571+GUAR.GUM 64.000 KGS)||||||||| |||1 no. of neulin tablet|1|Theophylline BP / EP / USP / PH.EUR Anhydrous Powder|||204.0 mg||| ||||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||7.00 mg||| |||||||||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015 it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Neulin 250mg Tablets -<br>(Theophylline 250 Mg +<br>Guar gum 8.750 Mg)<br>(9142857 No. of Tabs)<br>(Theop-	1 no. of neulin<br>tablet	1	Theophylline BP / EP / USP /<br>PH.EUR Anhydrous Powder	Theophylline BP / EP / USP /<br>PH.EUR Anhydrous Powder	255.0 mg
		2	Guar Gum IH (BP / EP / USP /<br>PH.EUR)		8.75 mg
2285.714+GUAR.GUM<br>80.000 KGS)<br>Neulin 300mg Tablets -<br>( Theophylline 300 Mg +
	1 no. of neulin<br>tablet	1	The<br>PH.	ophylline BP / EP / USP /<br>EUR Anhydrous Powder	306.0 mg

Guar gum 10.5 Mg)<br>(9142857 No.

300mg Tablets - ( Theophylline 300 Mg +||||||| |||1 no. of neulin tablet|1|The PH.|ophylline BP / EP / USP / EUR Anhydrous Powder|306.0 mg|| ||||||||| ||Guar gum 10.5 Mg) (9142857 No. of Tabs) (Theop- 2742.857+GUAR.GUM 96.000 KGS) 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||2|Guar Gum IH (BP / EP / USP / PH.EUR)||10.5 mg|| |||||||||

Case No.:953/15/82-	Party Name:COVALENT	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES PRIVATE	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0910062188	Defer Date:
:01/82/050/02410/AM19/	:09/24/040/00025/AM16/	16.06.2015

		ALC4/2018<br>HQ File<br>:01/82/050/02410/AM19/	ALC4/2018<br>HQ File<br>:01/82/050/02410/AM19/	LABORATORIES PRIVATE<br>LIMITED<br>ALC4/2018<br>22.03.2019<br>RLA File<br>:09/24/040/00025/AM16/<br>Lic.No/Date:0910062188<br>16.06.2015	LABORATORIES PRIVATE<br>LIMITED<br>ALC4/2018<br>22.03.2019<br>RLA File<br>:09/24/040/00025/AM16/<br>Lic.No/Date:0910062188<br>16.06.2015	LABORATORIES PRIVATE<br>LIMITED<br>ALC4/2018<br>22.03.2019<br>RLA File<br>:09/24/040/00025/AM16/<br>Lic.No/Date:0910062188<br>16.06.2015	LABORATORIES PRIVATE<br>LIMITED<br>ALC4/2018<br>22.03.2019<br>RLA File<br>:09/24/040/00025/AM16/<br>Lic.No/Date:0910062188<br>16.06.2015	Approved<br>Defer Date:	Approved<br>Defer Date:

LC4/2018 22.03.2019 RLA File :09/24/040/00025/AM16/ Lic.No/Date:0910062188 16.06.2015|Approved Defer Date:|Approved Defer Date:| |---|---|---|---|---|---|---|---|---|---| |||**Decision:**The Committee||considered the case as per agenda in the presence of Technical||||Experts and in|| |||the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was|||||||| |||decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as|||||||| |||applied by firm whichever is lower:|||||||| |18|||Export product|Qty.|Sl. No.|Import items||Qty.|| ||||Cefixime|1 kg|1|7-Phenylacetamideo-3-Chloromethyl||1.4219 kg|| |||||||Cephalosporonic Acid|Para||| |||||||Methoxybenzyl Ester (GCLE)|||| ||||||2|Triphenyl Phosphine||0.775 kg|| ||||||3|Activated Carbon||0.05 kg|| ||||||4|Dimethyl Formamide||2.80 kg|| ||||||5|Methylene Chloride||10.00 kg|| ||||||6|Mica Ester||0.82 kg|| |||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

	Case No.:1064/15/82-	Party Name:MALLADI	Meet No/Date:15/82-	Status:
	ALC4/2018	DRUGS &	ALC4/2018	Deferred
		PHARMACEUTICALS	22.03.2019
		LIMITED
19	HQ File	RLA File	Lic.No/Date:0410160680	Defer Date:
	:01/82/050/02521/AM19/	:04/24/040/00055/AM16/	16.06.2015
	Decision:RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Chennai.

Case No.:954/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Withdrawn
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510394585	Defer Date:
:01/82/050/02411/AM19/	:05/24/040/00089/AM16/	17.06.2015

20 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance

authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

has informed that the subject advance

authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

21	<br>Case No.:1065/15/82-<br>ALC4/2018	Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0410160689<br>18.06.2015	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02522/AM19/	RLA File<br>:04/24/040/00056/AM16/		Defer Date:
	Decision:RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Chennai.

Decision: RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Chennai.

Case No.:955/15/82-	Party Name:GLENMARK	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICALS LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310796905	Defer Date:
:01/82/050/02412/AM19/	:03/94/040/00242/AM16/	26.06.2015

4/2018**||PHARMACEUTICALS LTD.,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0310796905||Defer Date:| |:01/82/050/02412/AM19/||:03/94/040/00242/AM16/||26.06.2015|||

	Case No.:955/15/82-<br>ALC4/2018	Case No.:955/15/82-<br>ALC4/2018	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0310796905<br>26.06.2015	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0310796905<br>26.06.2015	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/02412/AM19/		RLA File<br>:03/94/040/00242/AM16/
22	<br>Decision:The Committee considered the case<br>the light of earlier decision taken by NC in its<br>decided to ratify the ad-hoc input output norms<br>applied by firm whichever is lower:<br> <br>Exportproduct<br>Qty.<br>Ciclopirox Gel 0.77% ( Pack 30<br>Gms) (Net wt. of Ciclopirox<br>USP is 7.623 Kgs.)<br>1 Pack<br>Ciclopirox Gel 0.77% ( Pack 45<br>Gms) (Net wt. of Ciclopirox<br>USP is 4.505 Kgs.)<br>1 Pack<br>Ciclopirox Gel 0.77% ( Pack 100<br>Gms) (Net wt. of Ciclopirox<br>USP is 7.700 Kgs.)<br>1 Pack<br>RA concerned maytake further necessaryaction				as per agenda in the presence of Technical Experts and in<br>Meeting No. 18/82-ALC4/2014, dated 18.02.2015, it was<br>under para 4.7 of HBP Vol. I as per details below or as<br>Sl.

necessaryaction||||as per agenda in the presence of Technical Experts and in Meeting No. 18/82-ALC4/2014, dated 18.02.2015, it was under para 4.7 of HBP Vol. I as per details below or as Sl. No. Import items Qty. 1 Ciclopirox USP 235.62 mg / 30 gm 1 Ciclopirox USP 352.967 mg / 45 gm 1 Ciclopirox USP 785.0 mg/ 100 gm asper above decision of NC.||||| |||Exportproduct||Qty.|Sl. No.|Import items||Qty.|| |||Ciclopirox Gel 0.77% ( Pack 30 Gms) (Net wt. of Ciclopirox USP is 7.623 Kgs.)||1 Pack|1|Ciclopirox USP||235.62 mg / 30 gm|| |||Ciclopirox Gel 0.77% ( Pack 45 Gms) (Net wt. of Ciclopirox USP is 4.505 Kgs.)||1 Pack|1|Ciclopirox USP||352.967 mg / 45 gm|| |||Ciclopirox Gel 0.77% ( Pack 100 Gms) (Net wt. of Ciclopirox USP is 7.700 Kgs.)||1 Pack|1|Ciclopirox USP||785.0 mg/ 100 gm|| ||||||asper above decision of NC.|||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 18/82-ALC4/2014, dated 18.02.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:956/15/82-	Party Name:GLENMARK	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICALS LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310796942	Defer Date:
:01/82/050/02413/AM19/	:03/94/040/00241/AM16/	30.06.2015

4/2018**||PHARMACEUTICALS LTD.,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0310796942||Defer Date:| |:01/82/050/02413/AM19/||:03/94/040/00241/AM16/||30.06.2015|||

	Case No.:956/15/82-<br>ALC4/2018	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,<br>RLA File<br>:03/94/040/00241/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0310796942<br>30.06.2015	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/02413/AM19/
23	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2013, dated 19.09.2013, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Lercanidipine Hydrochloride<br>1 kg<br>1<br>3,3 diphenylpropylamine<br>1.19 kg<br>2<br>Tetrahydrofuran<br>2.90 kg<br>3<br>Methylene<br>Dichloride/Methylene<br>Chloride/MDC<br>4.88 kg<br>4<br>1-Chloro-2-Methyl-2-Propanol<br>0.507 kg<br>5<br>Isopropyl Acetate<br>6.83 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

ene Chloride/MDC 4.88 kg 4 1-Chloro-2-Methyl-2-Propanol 0.507 kg 5 Isopropyl Acetate 6.83 kg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2013, dated 19.09.2013, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:957/15/82-	Party Name:GLENMARK	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICALS LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310797041	Defer Date:
:01/82/050/02414/AM19/	:03/94/040/00239/AM16/	02.07.2015

Export product	Qty.	Sl.<br>No.	Import items	Qty.
Cilostazol	1 kg	1	5-(4-chlorobutyl)-1-cyclohexyl-1H-Tetrazole	0.88 kg
		2	6-hydroxy-3,4-dihydro-1h-quinolin-2-one	0.59 kg

port product	Qty.	Sl.<br>No.	Import items	Qty.
Cilostazol	1 kg	1	5-(4-chlorobutyl)-1-cyclohexyl-1H-Tetrazole	0.88 kg
		2	6-hydroxy-3,4-dihydro-1h-quinolin-2-one	0.59 kg

Case No.:252/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Withdrawn
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510394796	Defer Date:
:01/82/050/01709/AM19/	:05/24/040/00151/AM16/	03.07.2015

25 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

Case No.:401/15/82-	Party Name:RATNAMANI BIO	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICALS &	ALC4/2018	Approved
	PHARMACEUTICALS PVT.	22.03.2019
	LTD
HQ File	RLA File	Lic.No/Date:3410041362	Defer Date:
:01/82/050/01858/AM19/	:34/24/040/00103/AM16/	09.07.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 11/82-ALC4/2014, dated 26.11.2014, it was 26 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 11/82-ALC4/2014, dated 26.11.2014, it was 26 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Exportproduct	Qty.	Sl.No.	Import items	Qty.
2,3-Dichloro Benzoic Acid	1 kg	1.	2,3-Dichloro Toluene	0.952 kg
2,3-Dichloro Benzoyl Cyanide	1 kg	1.	2,3-Dichloro Toluene	1.079 kg

	Case No.:958/15/82-	Party Name:MAGBRO		Meet No/Date:15/82-	Status:Deferred
	ALC4/2018	HEALTHCARE PVT.LTD.		ALC4/2018
				22.03.2019
27	HQ File	RLA File		Lic.No/Date:3010103559	Defer Date:
	:01/82/050/02415/AM19/	:30/24/040/00015/AM16/		10.07.2015
	Decision:RLA, Ludhianawas requested vide e-mail dated		05.04.2019 to furnish the		hard copy of 4.07
	application of subject Advance	Authorization. Application awaited from RLA,Ludhiana.

Decision: RLA, Ludhianawas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ludhiana.

|||

Decision: RLA, Ludhianawas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ludhiana.

	Case No.:959/15/82-	Party Name:DR REDDYS	Meet No/Date:15/82-	Status:
	ALC4/2018	LABORATORIES LIMITED	ALC4/2018	Deferred
			22.03.2019
28	HQ File	RLA File	Lic.No/Date:0910062340	Defer Date:
	:01/82/050/02416/AM19/	:09/24/040/00222/AM16/	16.07.2015
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:960/15/82-	Party Name:CLEAN	Meet No/Date:15/82-	Status:Withdrawn
ALC4/2018	SCIENCE AND	ALC4/2018
	TECHNOLOGY PVT.LTD.	22.03.2019
HQ File	RLA File	Lic.No/Date:3110065548	Defer Date:
:01/82/050/02417/AM19/	:31/83/040/00048/AM16/	21.07.2015

29 Decision: RLA, Pune vide e-mail dated 11.04.2019 has informed that the subject advance authorization hasbeen redeemed vide Redemption letter dated 19.01.2018 issued to firm.

|||

29 Decision: RLA, Pune vide e-mail dated 11.04.2019 has informed that the subject advance authorization hasbeen redeemed vide Redemption letter dated 19.01.2018 issued to firm.

	Case No:961/15/82-	Part Name:MALLADI	Meet No/Date:15/82-	Status:
30	.<br>ALC4/2018	y<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED	<br>ALC4/2018<br>22.03.2019	<br>Deferred
	HQ File<br>:01/82/050/02418/AM19/	RLA File<br>:04/24/040/00102/AM16/	Lic.No/Date:0410160849<br>30.07.2015	Defer Date:
	Decision:RLA, Chennai was	requested vide e-mail dated 05.04.2019 to furnish the hard		copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Chennai.


31	Case No.:962/15/82-<br>ALC4/2018	Party Name:VARTIKA<br>CHEMICALS &<br>PHARMACEUTICALS<br>P.LTD.	Meet No/Date:15/82-<br>ALC4/2018<br> <br>	Status:<br>Deferred
			22.03.2019
	HQ File<br>:01/82/050/02419/AM19/	RLA File<br>:13/24/040/00017/AM16/	Lic.No/Date:1310047941<br>03.08.2015<br>	Defer Date:
	Decision:RLA, Jaipur was	requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Jaipur.

||**Decision:**RLA, Jaipur was|requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07||| ||application of subject Advance Authorization. Application awaited from RLA,Jaipur.||||

	Case No.:963/15/82-	Party Name:MALLADI	Meet No/Date:15/82-	Status:
	ALC4/2018	DRUGS &	ALC4/2018	Deferred
		PHARMACEUTICALS	22.03.2019
		LIMITED
32	HQ File	RLA File	Lic.No/Date:0410160864	Defer Date:
	:01/82/050/02420/AM19/	:04/24/040/00104/AM16/	04.08.2015
	Decision:RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Chennai.

	Case No.:977/15/82-	Party Name:MAHAVIR	Meet No/Date:15/82-		Status:
	ALC4/2018	SYNTHESIS PRIVATE	ALC4/2018		Deferred
		LIMITED	22.03.2019
33	HQ File	RLA File	Lic.No/Date:5210041613		Defer Date:
	:01/82/050/02434/AM19/	:52/24/040/00027/AM16/	18.08.2015
	Decision:RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Surat.

ion:**RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard|||||copy of 4.07|| |||application of subject Advance Authorization. Application awaited||||from RLA,Surat.|||

Case No.:1016/15/82-	Party Name:EXPO FINE	Meet No/Date:15/82-	Status:Approved
ALC4/2018	CHEMICAL INDUSTRIES	ALC4/2018
		22.03.2019
HQ File	RLA File	Lic.No/Date:2410041807	Defer Date:
:01/82/050/02473/AM19/	:24/24/040/00011/AM16/	18.08.2015

	Case No.:1016/15/82-<br>ALC4/2018	Party Name:EXPO FINE<br>CHEMICAL INDUSTRIES	Party Name:EXPO FINE<br>CHEMICAL INDUSTRIES	Party Name:EXPO FINE<br>CHEMICAL INDUSTRIES	Party Name:EXPO FINE<br>CHEMICAL INDUSTRIES	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:Approved
	HQ File<br>:01/82/050/02473/AM19/	RLA File<br>:24/24/040/00011/AM16/				Lic.No/Date:2410041807<br>18.08.2015	Defer Date:
34	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied<br>by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>4-HYDROXYMETHYL-4-METHYL-<br>1-PHENYL-3-PYRAZOLIDONE<br>(PHENIDONE-D / DIMESONE-S)<br>1 kg<br>1<br>PHENYL HYDRAZINE<br>(HYDRAZINOBENZENE /<br>PHD)<br>1.25 kg<br>2<br>DIMETHYLOL PROPIONIC<br>ACID<br>1.40 kg<br>3<br>TOLUENE<br>1.00 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

br>(HYDRAZINOBENZENE / PHD) 1.25 kg 2 DIMETHYLOL PROPIONIC ACID 1.40 kg 3 TOLUENE 1.00 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||| || Export product||Qty.|Sl. No.|Import items||| ||4-HYDROXYMETHYL-4-METHYL- 1-PHENYL-3-PYRAZOLIDONE (PHENIDONE-D / DIMESONE-S)||1 kg|1|PHENYL HYDRAZINE (HYDRAZINOBENZENE / PHD)||| |||||2|DIMETHYLOL PROPIONIC ACID||| |||||3|TOLUENE||| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:964/15/82-	Party Name:H.J.AROCHEM	Meet No/Date:15/82-	Status:
ALC4/2018	PVT. LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810135908	Defer Date:
:01/82/050/02421/AM19/	:08/24/040/00139/AM16/	21.08.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 19/82-ALC4/2013, dated 02.01.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 35 applied by firm whichever is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
DIPHENYL OXIDE	1 kg	1	PHENOL	0.449kg
		2	MONO CHLORO BENZENE	0.774 kg
		3	CAUSTIC SODA FLAKES	0.425 kg
		4	CUPEROS OXIDE	0.049kg

Qty.|Sl. No.|Import items|Qty.| |---|---|---|---|---| |DIPHENYL OXIDE|1 kg|1|PHENOL|0.449kg| |||2|MONO CHLORO BENZENE|0.774 kg| |||3|CAUSTIC SODA FLAKES|0.425 kg| |||4|CUPEROS OXIDE|0.049kg|

Case No.:965/15/82-	Party Name:DHANUKA	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510395398	Defer Date:
:01/82/050/02422/AM19/	:05/23/040/00208/AM16/	21.08.2015

	Case No.:965/15/82-<br>ALC4/2018	Party Name:DHANUKA<br>LABORATORIES LTD.	Party Name:DHANUKA<br>LABORATORIES LTD.	Party Name:DHANUKA<br>LABORATORIES LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0510395398<br>21.08.2015	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0510395398<br>21.08.2015	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/02422/AM19/	RLA File<br>:05/23/040/00208/AM16/
36	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018, dated 16.10.2018, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

Experts and in the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018, dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl.No. Import items Qty. CEFUROXIME AXETIL AMORPHOUS USP/BP/IP/JP POWDER 1 kg 1 D-7ACA 0.752 kg 2 (Z)-2-Methoxyimino-2-(furyl-2-yl) acetic acid ammonium salt (SMIA) 0.700 kg 3 Phosphorous Pentachloride(PCl5) 0.784 kg 4 METHANOL 3.05 kg 5 Methylene Chloride 2.87 kg 6 CHLOROSULPHONYL ISOCYANATE (CSI) 0.53 kg 7 ACETONE 0.175 kg 8 TETRA METHYL GUANIDINE 0.215 kg 9 N,N DIMETHYL ACETAMIDE (DMAC) 1.94 kg 10 ETHYL ACETATE 1.84 kg 11 1-ACETOXYETHYLBROMIDE (AEB) 0.59 kg 12 ACTIVATED CARBON 0.100 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||| ||Export product|Qty.|Sl.No.|Import items||Qty.|| ||CEFUROXIME AXETIL AMORPHOUS USP/BP/IP/JP POWDER| 1 kg|1|D-7ACA||0.752 kg|| ||||2|(Z)-2-Methoxyimino-2-(furyl-2-yl) acetic acid ammonium salt (SMIA)||0.700 kg|| ||||3|Phosphorous Pentachloride(PCl5)||0.784 kg|| ||||4|METHANOL||3.05 kg|| ||||5|Methylene Chloride||2.87 kg|| ||||6|CHLOROSULPHONYL ISOCYANATE (CSI)||0.53 kg|| ||||7|ACETONE||0.175 kg|| ||||8|TETRA METHYL GUANIDINE||0.215 kg|| ||||9|N,N DIMETHYL ACETAMIDE (DMAC)||1.94 kg|| ||||10|ETHYL ACETATE||1.84 kg||

||6|CHLOROSULPHONYL ISOCYANATE (CSI)||0.53 kg|| ||||7|ACETONE||0.175 kg|| ||||8|TETRA METHYL GUANIDINE||0.215 kg|| ||||9|N,N DIMETHYL ACETAMIDE (DMAC)||1.94 kg|| ||||10|ETHYL ACETATE||1.84 kg|| ||||11|1-ACETOXYETHYLBROMIDE (AEB)||0.59 kg|| ||||12|ACTIVATED CARBON||0.100 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

37	Case No.:966/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02423/AM19/	Party Name:GRANULES<br>INDIA LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
		RLA File<br>:09/24/040/00303/AM16/	Lic.No/Date:0910062538<br>27.08.2015	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Case No.:967/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Withdrawn
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510395453	Defer Date:
:01/82/050/02424/AM19/	:05/24/040/00028/AM16/	27.08.2015

ALC4/2018**||SOLVENTS LTD.,||ALC4/2018||Withdrawn| ||||||22.03.2019||| ||HQ File||RLA File||Lic.No/Date:0510395453||Defer Date:| ||:01/82/050/02424/AM19/||:05/24/040/00028/AM16/||27.08.2015|||

38 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

Case No.:968/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510395454	Defer Date:
:01/82/050/02425/AM19/	:05/24/040/00033/AM16/	27.08.2015

	Case No.:968/15/82-<br>ALC4/2018	Party Name:PCL OIL &<br>SOLVENTS LTD.,<br>RLA File<br>:05/24/040/00033/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0510395454<br>27.08.2015	Status:<br>Approved
	HQ File<br>:01/82/050/02425/AM19/			Defer Date:
39	<br>Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no.

|---|---|---|---| ||HQ File :01/82/050/02425/AM19/|||Defer Date:| |39| **Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 13/82-ALC4/2018 dated 14.01.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: Export product Qty. Sl. No. Import items Qty. PVC PLASTICIZER (DOP) 1 kg 1 PHTHALIC ANHYDRIDE 0.3797 kg 2 2-ETHYLHEXANOL (OCTANOL) 0.700 kg RA maytake appropriate action asper the decision of Norms Committee.||||

40	Case No.:486/15/82-<br>ALC4/2018	Party Name:GLENMARK<br>PHARMACEUTICALS LTD.,<br>RLA File<br>:03/94/040/00250/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0310798582<br>31.08.2015	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01943/AM19/			Defer Date:
	Decision:RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard<br>application of subject Advance Authorization. Application awaited from RLA,Mumbai.			copy of 4.07

Decision: RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Mumbai.

4.07|

Decision: RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Mumbai.

41	Case No.:969/15/82-<br>ALC4/2018	Party Name:SOMU<br>SOLVENTS PVT. LTD<br> <br> <br>	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02426/AM19/	RLA File<br>:07/24/040/00175/AM16/<br> <br>	Lic.No/Date:0710108673<br>02.09.2015	Defer Date:
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.			copy of 4.07

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

Case No.:970/15/82-	Party Name:ADVANCE	Meet No/Date:15/82-	Status:
ALC4/2018	PETROCHEMICALS	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0810136044	Defer Date:
:01/82/050/02427/AM19/	:08/24/040/00176/AM16/	14.09.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 2/82-ALC4/2018, dated 16.05.2018, it was 42 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

s Meeting No. 2/82-ALC4/2018, dated 16.05.2018, it was 42 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

	Export Product	Qty.	Sl. No.	Import items	Qty.
	DIETHYLENE GLYCOL	1 kg	1	METHANOL	0.280 kg
	MONO METHYL ETHER		2	ETHYLENE OXIDE(EO)	0.748kg
RA concerned maytake further necessaryaction as			per above decision of NC.

Case No.:971/15/82-	Party Name:IND-SWIFT	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:2210015309	Defer Date:
:01/82/050/02428/AM19/	:22/24/040/00043/AM16/	14.09.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was 43 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl. No.	Import items	Qty.
CLARITHROMYCIN<br>GRANULES<br>33%(SUSPENSION GRADE)	1kg	1.	CLARITHROMYCIN	0.3333 kg
		2.	CARBOPOL	0.25 kg
		3.	HPMC PHTHALATE	0.44 kg

t	Qty.	Sl. No.	Import items	Qty.
CLARITHROMYCIN<br>GRANULES<br>33%(SUSPENSION GRADE)	1kg	1.	CLARITHROMYCIN	0.3333 kg
		2.	CARBOPOL	0.25 kg
		3.	HPMC PHTHALATE	0.44 kg

Case No.:261/15/82-	Party Name:PCL OIL &	Meet No/Date:15/82-	Status:
ALC4/2018	SOLVENTS LTD.,	ALC4/2018	Withdrawn
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510395614	Defer Date:
:01/82/050/01718/AM19/	:05/24/040/00275/AM16/	15.09.2015

44 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 3/82-ALC4.2014 dated 08.05.2014 .

45	Case No.:405/15/82-<br>ALC4/2018	Party Name:SHIVA<br>PHARMACHEM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	HQ File<br>:01/82/050/01862/AM19/	RLA File<br>:34/24/040/00139/AM16/	Lic.No/Date:3410041522<br>16.09.2015	Defer Date:
	Decision:RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Vadodara.

Decision: RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Vadodara.

Case No.:972/15/82-	Party Name:MSN	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACHEM PRIVATE	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0910062627	Defer Date:
:01/82/050/02429/AM19/	:09/24/040/00356/AM16/	16.09.2015

Exportproduct	Qty.	Sl.No.	Import items	Qty.
DARUNAVIR	1 kg	1.	2,5-Dioxopyrrolidin-1-yl(3R,3aS,6aR)-<br>hexahydrofuro [2,3-b]furan-3-yl carbonate	0.787 kg
		2.	4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-<br>phenylbutyl)-N-isobutylbenzenesulfonamide	1.14 kg

Case No.:974/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710108769	Defer Date:
:01/82/050/02431/AM19/	:07/24/040/00207/AM16/	22.09.2015

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710108769||Defer Date:| |:01/82/050/02431/AM19/||:07/24/040/00207/AM16/||22.09.2015|||

	Case No.:974/15/82-<br>ALC4/2018	Case No.:974/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02431/AM19/		RLA File<br>:07/24/040/00207/AM16/			Lic.No/Date:0710108769<br>22.09.2015		Defer Date:
47	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Exportproduct<br> Qty.<br>Sl.No.<br>Import items<br>Qty.<br>SYNDOL TABS -<br>(Paracetamol 450mg +<br>Caffeine 30mg +<br>Doxylamine Succinate 5mg<br>+ Codeine Phosphate 10mg<br>Colour Yellow 14037-<br>1.632MG Tablets) (Para -<br>9000.000+Caff -600.000+<br>Doxy-100.000+Codeine -<br>200.000 Colour Yellow<br>14037-32640 KGS) (No. of<br>Tablets 20000000)<br>1 million<br>tablets<br>1.<br>DOXYLAMINE SUCCINATE USP<br>/Ph.

Para - 9000.000+Caff -600.000+ Doxy-100.000+Codeine - 200.000 Colour Yellow 14037-32640 KGS) (No. of Tablets 20000000) 1 million tablets 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR YELLOW 14037 IH 1.632 kg ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg+Colour Yellow Lake- 4.56mg Colour Yellow WS- 2.43mg Tablets (Para - 33750.000 +Codeine - 750.000 + Caff -3375.000+ Doxy-375.000 Colour Yellow Lake-342.000 1 million tablets 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR YELLOW 14037 IH 2.43 kg 4. COLOUR QUINOLINE YELLOW WS (SPECTRACOL) 4.56 kg|||||||| ||Exportproduct|Qty.||Sl.No.|Import items||Qty.|| ||SYNDOL TABS - (Paracetamol 450mg + Caffeine 30mg + Doxylamine Succinate 5mg + Codeine Phosphate 10mg Colour Yellow 14037- 1.632MG Tablets) (Para - 9000.000+Caff -600.000+ Doxy-100.000+Codeine - 200.000 Colour Yellow 14037-32640 KGS) (No. of Tablets 20000000)|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph.

blets) (Para - 9000.000+Caff -600.000+ Doxy-100.000+Codeine - 200.000 Colour Yellow 14037-32640 KGS) (No. of Tablets 20000000)|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg|| |||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg|| |||||3.|COLOUR YELLOW 14037 IH||1.632 kg|| ||ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg+Colour Yellow Lake- 4.56mg Colour Yellow WS- 2.43mg Tablets (Para - 33750.000 +Codeine - 750.000 + Caff -3375.000+ Doxy-375.000 Colour Yellow Lake-342.000|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg|| |||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg|| |||||3.|COLOUR YELLOW 14037 IH||2.43 kg|| |||||4.|COLOUR QUINOLINE YELLOW WS (SPECTRACOL)||4.56 kg||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Colour Yellow WS-182.250<br>KGS) (No. of Tablets<br>75000000)
BETAPYN TABS -<br>(Paracetamol 450mg +<br>Caffeine 50mg +<br>Doxylamine Succinate 5mg<br>+ Colour Yellow 14037-<br>1.848MG Codeine<br>Phosphate 10mg Tablets<br>(Para -2250.000+ Caff -<br>250.000 Doxy-<br>25.000+Colour Yellow<br>14037-9.240 Codeine -50.00<br>KGS (No. of Tablets<br>5000000)	1 million<br>tablets	1.	DOXYLAMINE SUCCINATE USP<br>/Ph. Eur Grade	5.10 kg
		2.	CODIENE PHOSPHATE BP / EP /<br>USP / PH.EUR	10.2 kg
		3.	COLOUR YELLOW 14037 IH	Do not<br>match with<br>MBF
PYNSTOP TABS -<br>(Paracetamol 450mg +<br>Caffeine 45mg +<br>Doxylamine Succinate 5mg<br>+ Codeine Phosphate 10mg<br>Tablets (Para - 2250.000+<br>Caff -225.000+ Doxy-<br>25.000+Codeine - 50.000<br>Kgs) (No. of Tablets<br>5000000)	1 million<br>tablets	1.	DOXYLAMINE SUCCINATE USP<br>/Ph. Eur Grade	5.10 kg
		2.	CODIENE PHOSPHATE BP / EP /<br>USP / PH.EUR	10.2 kg

Case No.:975/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710108770	Defer Date:
:01/82/050/02432/AM19/	:07/24/040/00206/AM16/	22.09.2015

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710108770||Defer Date:| |:01/82/050/02432/AM19/||:07/24/040/00206/AM16/||22.09.2015|||

	Case No.:975/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,<br>RLA File<br>:07/24/040/00206/AM16/	Party Name:ADCOCK<br>INGRAM LTD,<br>RLA File<br>:07/24/040/00206/AM16/	Party Name:ADCOCK<br>INGRAM LTD,<br>RLA File<br>:07/24/040/00206/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/02432/AM19/				Lic.No/Date:0710108770<br>22.09.2015
48	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Exportproduct<br> Qty.<br>Sl.No.<br>Import items<br>Qty.<br>SYNDOL<br>TABS<br>-<br>(Paracetamol<br>450mg<br>+<br>Caffeine<br>30mg<br>+<br>Doxylamine Succinate 5mg<br>+ Codeine Phosphate 10mg<br>Colour<br>Yellow<br>14037-<br>1.632MG Tablets) (Para -<br>9000.000+Caff<br>-600.000+<br>Doxy-100.000+Codeine<br>-<br>200.000<br>Colour<br>Yellow<br>14037-32640 KGS) (No. of<br>1 million<br>tablets<br>1.<br>DOXYLAMINE<br>SUCCINATE<br>USP /Ph.

ets) (Para - 9000.000+Caff -600.000+ Doxy-100.000+Codeine - 200.000 Colour Yellow 14037-32640 KGS) (No. of 1 million tablets 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR YELLOW 14037 IH 1.632 kg|||||| ||Exportproduct|Qty.|Sl.No.|Import items||Qty.| ||SYNDOL TABS - (Paracetamol 450mg + Caffeine 30mg + Doxylamine Succinate 5mg + Codeine Phosphate 10mg Colour Yellow 14037- 1.632MG Tablets) (Para - 9000.000+Caff -600.000+ Doxy-100.000+Codeine - 200.000 Colour Yellow 14037-32640 KGS) (No. of|1 million tablets|1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg| ||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg| ||||3.|COLOUR YELLOW 14037 IH||1.632 kg|

Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Tablets 20000000)
ADCO<br>DOL<br>TABS<br>(Paracetamol<br>450mg<br>+<br>Codeine Phosphate 10mg+<br>Caffeine<br>45mg<br>+<br>Doxylamine<br>Succinate<br>5mg+Colour Yellow Lake-<br>4.56mg Colour Yellow WS-<br>2.43mg<br>Tablets<br>(Para<br>-<br>33750.000<br>+Codeine<br>-<br>750.000 + Caff -3375.000+<br>Doxy-375.000<br>Colour<br>Yellow<br>Lake-342.000<br>Colour Yellow WS-182.250<br>KGS)<br>(No.<br>of<br>Tablets<br>75000000)	1 million<br>tablets	1.	DOXYLAMINE<br>SUCCINATE<br>USP /Ph. Eur Grade	5.10 kg
		2.	CODIENE PHOSPHATE BP / EP /<br>USP / PH.EUR	10.2 kg
		3.	COLOUR YELLOW 14037 IH	2.43 kg
		4.	COLOUR QUINOLINE YELLOW<br>WS (SPECTRACOL)	4.56 kg
BETAPYN<br>TABS<br>-<br>(Paracetamol<br>450mg<br>+<br>Caffeine<br>50mg<br>+<br>Doxylamine Succinate 5mg<br>+ Colour Yellow 14037-<br>1.848MG<br>Codeine<br>Phosphate<br>10mg<br>Tablets<br>(Para -2250.000+ Caff -<br>250.000<br>Doxy-<br>25.000+Colour<br>Yellow<br>14037-9.240 Codeine -50.00<br>KGS<br>(No.<br>of<br>Tablets<br>5000000)	1 million<br>tablets	1.	DOXYLAMINE<br>SUCCINATE<br>USP /Ph.

-2250.000+ Caff - 250.000 Doxy- 25.000+Colour Yellow 14037-9.240 Codeine -50.00 KGS (No. of Tablets 5000000)|1 million tablets|1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade|5.10 kg| ||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR|10.2 kg| ||||3.|COLOUR YELLOW 14037 IH|Do not match with MBF| ||PYNSTOP TABS - (Paracetamol 450mg + Caffeine 45mg + Doxylamine Succinate 5mg + Codeine Phosphate 10mg Tablets (Para - 2250.000+ Caff -225.000+ Doxy- 25.000+Codeine - 50.000 Kgs) (No. of Tablets 5000000)|1 million tablets|1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade|5.10 kg| ||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR|10.2 kg|

49	Case No.:258/15/82-<br>ALC4/2018	Party Name:DR REDDYS<br>LABORATORIES LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	HQ File<br>:01/82/050/01715/AM19/	RLA File<br>:09/24/040/00308/AM16/	Lic.No/Date:0910062652<br>23.09.2015	Defer Date:
	Decision:RLA, Hyderabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Case No.:973/15/82-	Party Name:OTSUKA	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICAL ( INDIA )	ALC4/2018	Withdrawn
	PRIVATE LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0510395745	Defer Date:
:01/82/050/02430/AM19/	:05/24/040/00165/AM16/	28.09.2015

AL ( INDIA )||ALC4/2018||Withdrawn| ||||PRIVATE LIMITED||22.03.2019||| ||HQ File||RLA File||Lic.No/Date:0510395745||Defer Date:| ||:01/82/050/02430/AM19/||:05/24/040/00165/AM16/||28.09.2015|||

50 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 11/82-ALC4.2014 dated 26.11.2014 .

Case No.:976/15/82-	Party Name:UMA	Meet No/Date:15/82-	Status:
ALC4/2018	ENTERPRISE	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136151	Defer Date:
:01/82/050/02433/AM19/	:08/24/040/00189/AM16/	05.10.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 6/82-ALC4/2018, dated 26.07.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 51 applied by firm whichever is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
META CHLOROPER<br>BENZOIC ACID	1 kg	1	META CHLORO BENZOYL<br>CHLORIDE	1.00 kg
		2	TERTIARY BUTANOL	0.50 kg

ver is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
META CHLOROPER<br>BENZOIC ACID	1 kg	1	META CHLORO BENZOYL<br>CHLORIDE	1.00 kg
		2	TERTIARY BUTANOL	0.50 kg

Case No.:545/15/82-	Party Name:SUPRIYA	Meet No/Date:15/82-	Status:Approved
ALC4/2018	LIFESCIENCE LTD	ALC4/2018
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310799218	Defer Date:
:01/82/050/02002/AM19/	:03/95/040/00484/AM16/	06.10.2015

Export	product		Qty.	Sl.	Import items	Qty.
				No.
Methy	Cobalamin	JP	1 kg	1	VITAMIN B12 (Cyanocobalamin)	0.95 kg
(Mecobalamin)

53	Case No.:259/15/82-<br>ALC4/2018	Party Name:CADILA<br>PHARMACEUTICALS LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0810136251<br>12.10.2015	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/01716/AM19/	RLA File<br>:08/24/040/00222/AM16/
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision:**RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Hyderabad.||||

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:256/15/82-	Party Name:ARVEE	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES INDIA	ALC4/2018	Approved
	PRIVATE LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0810136270	Defer Date:
:01/82/050/01713/AM19/	:08/24/040/00228/AM16/	13.10.2015

Export product	Qty.	Sl.<br>No.	Import items	Qty.
Dimethyl 5-Nitroisophthalate	1 kg	1	Isophthalic Acid	0.857 kg
		2	Methanol	0.89 kg

plied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
Dimethyl 5-Nitroisophthalate	1 kg	1	Isophthalic Acid	0.857 kg
		2	Methanol	0.89 kg

55	Case No.:978/15/82-<br>ALC4/2018	Party Name:HETERO LABS<br>LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0910062715<br>13.10.2015	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/02435/AM19/	RLA File<br>:09/24/040/00434/AM16/
	Decision:RLA, Hyderabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:979/15/82-	Party Name:AMANTA	Meet No/Date:15/82-	Status:
ALC4/2018	HEALTHCARE LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136352	Defer Date:
:01/82/050/02436/AM19/	:08/24/040/00245/AM16/	20.10.2015

ALC4/2018**||HEALTHCARE LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0810136352||Defer Date:| |:01/82/050/02436/AM19/||:08/24/040/00245/AM16/||20.10.2015|||

|||ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/0

/ Lic.No/Date:0810136352 20.10.2015 Defer Date:|ALC4/2018 HEALTHCARE LIMITED ALC4/2018 22.03.2019 Approved HQ File :01/82/050/02436/AM19/ RLA File :08/24/040/00245/AM16/ Lic.No/Date:0810136352 20.10.2015 Defer Date:| |---|---|---|---|---|---|---|---|---| |||**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and in||||||| |||the light of earlier decision taken by NC in|||its Meeting No. 8/82-ALC4/2018, dated 31.08.2018, it was|||| |||decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as||||||| |||applied by firm whichever is lower:||||||| ||||Export product|Qty.|Sl.|Import items|Qty.|| |56|||||No.|||| ||||SODIUM HYALURONATE|1 Number|1|SODIUM HYALURONATE|20 mg/10 ml Packs|| ||||EYE DROPS 0.2% W/V|||(HA-EP1)||| ||||PERBORATE (OUR XILIN|||||| ||||HA)|||||| ||||(EACH 10ML EYE DROPS|||||| ||||CONTAINING SODIUM|||||| ||||HYALURONATE 20MG)|||||| ||||(NET CONTENT OF|||||| ||||SODIUM HYALURONATE|||||| ||||20KGS)|||||| |||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:980/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710108960	Defer Date:
:01/82/050/02437/AM19/	:07/24/040/00243/AM16/	27.10.2015

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710108960||Defer Date:| |:01/82/050/02437/AM19/||:07/24/040/00243/AM16/||27.10.2015|||

	Decision:The Committee considered the case as	Decision:The Committee considered the case as	Decision:The Committee considered the case as	Decision:The Committee considered the case as	per agenda in the presence of Technical Experts and in	per agenda in the presence of Technical Experts and in	per agenda in the presence of Technical Experts and in	per agenda in the presence of Technical Experts and in
	the light of earlier decision taken by NC			in its Meeting No. 5/82-ALC4/2015, dated		25.06.2015, it		was
	decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per					details below or as
	applied by firm whichever is lower:
		Export product	Qty.	Sl.	Import items		Qty.
				No.
		Neulin 125mg Tablets -	1 no. of	1.	Theophylline Anhydrous Powder		127.5 mg
57		Theophylline 125 Mg	Neulin
		+Guar gum 4.375 Mg	Tablet	2.	Guar Gum IH		4.375 mg
		(Theop-1000.000
		+GUAR.GUM 35.000
		KGS) (No. of Tabs -
		8000000)
		Neulin 200mg Tablets -	1 no. of	1	Theophylline Anhydrous Powder		204.0 mg
		Theophylline 200 Mg +	neulin tablet
		Guar gum 7.00 Mg		2	Guar Gum IH		7.00 mg
		(Theop-
		1857.143+GUAR.GUM
		65.000 KGS) (No. of
		Tabs - 9285714)

||Theophylline 200 Mg +|neulin tablet|||||| ||||Guar gum 7.00 Mg||2|Guar Gum IH||7.00 mg|| ||||(Theop-||||||| ||||1857.143+GUAR.GUM||||||| ||||65.000 KGS) (No. of||||||| ||||Tabs - 9285714)|||||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

1 no. of<br>neulin tablet	1	Theophylline Anhydrous Powder	255.0 mg
	2	Guar Gum IH	8.75 mg
1 no. of<br>neulin tablet	1	Theophylline Anhydrous Powder	306.0 mg
	2	Guar Gum IH	10.5 mg

e Anhydrous Powder|255.0 mg|| |---|---|---|---|---|---|---| ||||2|Guar Gum IH|8.75 mg|| |||1 no. of neulin tablet|1|Theophylline Anhydrous Powder|306.0 mg|| ||||2|Guar Gum IH|10.5 mg|| ||||||||

Case No.:981/15/82-	Party Name:OTSUKA	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICAL ( INDIA )	ALC4/2018	Withdrawn
	PRIVATE LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0510396053	Defer Date:
:01/82/050/02438/AM19/	:05/24/040/00311/AM16/	29.10.2015

58 Decision: CLA, New Delhi vide e-mail dated 12.04.2019 has informed that the subject advance authorization was issued to firm on repeat basis taking cue from earlier decision taken by NC-3 in its Meeting No. 11/82-ALC4.2014 dated 26.11.2014 .

Case No.:982/15/82-	Party Name:HETERO LABS	Meet No/Date:15/82-	Status:
ALC4/2018	LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910062797	Defer Date:
:01/82/050/02439/AM19/	:09/24/040/00456/AM16/	29.10.2015

--|---| |ALC4/2018||LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0910062797||Defer Date:| |:01/82/050/02439/AM19/||:09/24/040/00456/AM16/||29.10.2015|||

	Case No.:982/15/82-<br>ALC4/2018	Case No.:982/15/82-<br>ALC4/2018	Party Name:HETERO LABS<br>LIMITED<br>RLA File<br>:09/24/040/00456/AM16/	Party Name:HETERO LABS<br>LIMITED<br>RLA File<br>:09/24/040/00456/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0910062797<br>29.10.2015	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0910062797<br>29.10.2015	Status:<br>Approved
	HQ File<br>:01/82/050/02439/AM19/						Defer Date:
59	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 9/82-ALC4/2014, dated 20.10.2014, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

l Experts and in the light of earlier decision taken by NC in its Meeting No. 9/82-ALC4/2014, dated 20.10.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. LOPINAVIR 1 kg 1. L-Valine 0.761 kg 2. Methyl Chloroformate 1.23 kg 3. Acrylonitrile 0.38 kg 4. (2S,3S,5S)-2-amino-3-hydroxy-5- (tert.butyloxycrbonylamino)-1,6-diphenyl hexane 1.35 kg 5. 4-Dimethyl amino pyridine 0.0386 kg 6. Imidazole 1.50 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||| ||Export product|Qty.|Sl. No.|Import items||Qty.|| ||LOPINAVIR|1 kg|1.|L-Valine||0.761 kg|| ||||2.|Methyl Chloroformate||1.23 kg|| ||||3.|Acrylonitrile||0.38 kg|| ||||4.|(2S,3S,5S)-2-amino-3-hydroxy-5- (tert.butyloxycrbonylamino)-1,6-diphenyl hexane||1.35 kg|| ||||5.|4-Dimethyl amino pyridine||0.0386 kg|| ||||6.|Imidazole||1.50 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 9/82-ALC4/2014, dated 20.10.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 9/82-ALC4/2014, dated 20.10.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:983/15/82-	Party Name:KARNATAKA	Meet No/Date:15/82-	Status:
ALC4/2018	ANTIBIOTICS &	ALC4/2018	Approved
	PHARMACEUTICALS LTD.,	22.03.2019
HQ File	RLA File	Lic.No/Date:0710108975	Defer Date:
:01/82/050/02440/AM19/	:07/24/040/00231/AM16/	30.10.2015

	Case No.:983/15/82-<br>ALC4/2018	Party Name:KARNATAKA<br>ANTIBIOTICS &<br>PHARMACEUTICALS LTD.,	Party Name:KARNATAKA<br>ANTIBIOTICS &<br>PHARMACEUTICALS LTD.,	Party Name:KARNATAKA<br>ANTIBIOTICS &<br>PHARMACEUTICALS LTD.,	Party Name:KARNATAKA<br>ANTIBIOTICS &<br>PHARMACEUTICALS LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02440/AM19/	RLA File<br>:07/24/040/00231/AM16/				Lic.No/Date:0710108975<br>30.10.2015		Defer Date:
60	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. CO-AMOXICILLIN 1.2GM INJ (AMOXICILLIN 1G & CLAVULANIC 200MG FOR INJECTION) VIAL SIZE 20ML 1 Number 1 AMOXICILLIN SODIUM WITH POTASSIUM CLAVULANATE MIXTURE STERILE (5:1)BP (704.00 KGA) 1320 mg / vial RA concerned maytake further necessaryaction asper above decision of NC.|||||||| || Export product||Qty.|Sl. No.|Import items||Qty.|| ||CO-AMOXICILLIN 1.2GM INJ (AMOXICILLIN 1G & CLAVULANIC 200MG FOR INJECTION) VIAL SIZE 20ML||1 Number|1|AMOXICILLIN SODIUM WITH POTASSIUM CLAVULANATE MIXTURE STERILE (5:1)BP (704.00 KGA)||1320 mg / vial|| ||RA concerned maytake further necessaryaction|||asper above decision of NC.|||||

its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

61	Case No.:322/15/82-<br>ALC4/2018	Party Name:HESTER<br>BIOSCIENCES LIMITED<br>RLA File<br>:08/24/040/00270/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01779/AM19/		Lic.No/Date:0810136418<br>02.11.2015	Defer Date:
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Ahmedabad.

Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

Case No.:549/15/82-	Party Name:NEW ALLIANCE	Meet No/Date:15/82-	Status:
ALC4/2018	DYE-CHEM PVT. LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310800362	Defer Date:
:01/82/050/02006/AM19/	:03/95/040/00574/AM16/	23.11.2015

s Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 62 applied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
CALCIUM DISODIUM EDTA<br>(CA CONTENT 10%+/-<br>0.5%)[EDTA CALCIUM 10%]	1 kg	1	ETHYLENE DIAMINE<br>TETRA ACETIC ACID<br>(EDTA ACID)	0.791 kg

63	Case No.:984/15/82-<br>ALC4/2018	Party Name:BELOOR BAYIR<br>BIOTECH LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0710109127<br>03.12.2015	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/02441/AM19/	RLA File<br>:07/24/040/00287/AM16/
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

Case No.:987/15/82-	Party Name:UMA	Meet No/Date:15/82-	Status:
ALC4/2018	ENTERPRISE	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136677	Defer Date:
:01/82/050/02444/AM19/	:08/24/040/00287/AM16/	07.12.2015

---| |ALC4/2018||ENTERPRISE||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0810136677||Defer Date:| |:01/82/050/02444/AM19/||:08/24/040/00287/AM16/||07.12.2015|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 6/82-ALC4/2018, dated 26.07.2018, it was 64 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
META CHLOROPER<br>BENZOIC ACID	1 kg	1	META CHLORO BENZOYL CHLORIDE	1.00 kg
		2	TERTIARY BUTANOL	0.50 kg

65	Case No.:985/15/82-<br>ALC4/2018	Party Name:HETERO DRUGS<br>LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0910062959<br>10.12.2015	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/02442/AM19/	RLA File<br>:09/24/040/00548/AM16/
	Decision:RLA, Hyderabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Case No.:986/15/82-	Party Name:SWISS	Meet No/Date:15/82-	Status:
ALC4/2018	EXPORTS PVT. LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136701	Defer Date:
:01/82/050/02443/AM19/	:08/24/040/00292/AM16/	10.12.2015

ALC4/2018*||EXPORTS PVT. LTD.||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0810136701||Defer Date:| |:01/82/050/02443/AM19/||:08/24/040/00292/AM16/||10.12.2015|||

	Case No.:986/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02443/AM19/	Party Name:SWISS<br>EXPORTS PVT. LTD.	Party Name:SWISS<br>EXPORTS PVT. LTD.	Party Name:SWISS<br>EXPORTS PVT. LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0810136701<br>10.12.2015	Status:<br>Approved	Status:<br>Approved
		RLA File<br>:08/24/040/00292/AM16/				Defer Date:
66	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018 , it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>AMOXICILLIN<br>AND<br>CLAVULANATE<br>POTASSIUM<br>TABLETS<br>USP<br>625MG<br>/<br>CO-<br>AMOXICLAV TABLETS BP 625MG<br>(600000<br>Tablets)<br>AMOXICILLIN<br>AND<br>CLAVULANATE<br>POTASSIUM<br>TABLETS<br>USP<br>1GM<br>/<br>CO-<br>AMOXICLAV TABLETS BP 1GM<br>(200000 Tablets)<br>1 Number<br>1<br>RELEVANT BULK DRUG<br>POTASSIUM<br>CLAVULANATE DILUTED<br>IP WITH<br>MICROCRYSTALLINE<br>CELLULOSE (1:1)<br>303.773<br>mg / tablet<br>RA concerned maytake further necessaryaction asper above decision of NC.

DRUG POTASSIUM CLAVULANATE DILUTED IP WITH MICROCRYSTALLINE CELLULOSE (1:1) 303.773 mg / tablet RA concerned maytake further necessaryaction asper above decision of NC.||||||| ||Export product||Qty.|Sl. No.|Import items||Qty.| ||AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP 625MG / CO- AMOXICLAV TABLETS BP 625MG (600000 Tablets) AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP 1GM / CO- AMOXICLAV TABLETS BP 1GM (200000 Tablets)||1 Number|1|RELEVANT BULK DRUG POTASSIUM CLAVULANATE DILUTED IP WITH MICROCRYSTALLINE CELLULOSE (1:1)||303.773 mg / tablet| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018 , it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

ts Meeting No. 12/82-ALC4/2018, dated 12.12.2018 , it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

67	Case No.:262/15/82-<br>ALC4/2018	Party Name:BODAL<br>CHEMICALS LTD<br>RLA File<br>:08/24/040/00302/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01719/AM19/		Lic.No/Date:0810136714<br>11.12.2015	Defer Date:
	Decision:RLA, Ahmedabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Ahmedabad.

Case No.:989/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109183	Defer Date:
:01/82/050/02446/AM19/	:07/24/040/00319/AM16/	21.12.2015

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710109183||Defer Date:| |:01/82/050/02446/AM19/||:07/24/040/00319/AM16/||21.12.2015|||

	Case No.:989/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02446/AM19/	RLA File<br>:07/24/040/00319/AM16/	Lic.No/Date:0710109183<br>21.12.2015	Defer Date:
68	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Neulin 125mg Tablets -<br>Theophylline 125 Mg +Guar<br>gum 4.375 Mg<br>(Theop-1000.000<br>+GUAR.GUM 35.000 KGS)<br>(No. of Tabs - 8000000)<br>1 no. of<br>Neulin Tablet<br>1.<br>Theophylline Anhydrous<br>Powder<br>127.5 mg<br>2.<br>Guar Gum IH<br>4.375 mg<br>Neulin 200mg Tablets -<br>Theophylline 200 Mg + Guar<br>gum 7.00 Mg<br>(Theop-1857.143+GUAR.GUM<br>65.000 KGS) (No. of Tabs -<br>9285714)<br>1 no. of neulin<br>tablet<br>1<br>Theophylline Anhydrous<br>Powder<br>204.0 mg<br>2<br>Guar Gum IH<br>7.00 mg<br>Neulin 250mg Tablets -<br>Theophylline 250 Mg + Guar<br>gum 8.750 Mg<br>(Theop-2000.000+GUAR.GUM<br>70.000 KGS) (No. of Tabs -<br>8000000)<br>1 no.

owder 204.0 mg 2 Guar Gum IH 7.00 mg Neulin 250mg Tablets - Theophylline 250 Mg + Guar gum 8.750 Mg (Theop-2000.000+GUAR.GUM 70.000 KGS) (No. of Tabs - 8000000) 1 no. of neulin tablet 1 Theophylline Anhydrous Powder 255.0 mg 2 Guar Gum IH 8.75 mg Neulin 300mg Tablets - Theophylline 300 Mg + Guar gum 10.5 Mg (Theop-2571.429+GUAR.GUM 90.000 KGS) (No. of Tabs - 8571429) 1 no. of neulin tablet 1 Theophylline Anhydrous Powder 306.0 mg 2 Guar Gum IH 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

69	Case No.:1030/15/82-<br>ALC4/2018	Party Name:SWATI<br>MENTHOL & ALLIED<br>CHEMICALS LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:Deferred
	HQ File<br>:01/82/050/02487/AM19/	RLA File<br>:29/21/040/00029/AM16/	Lic.No/Date:2910025235<br>21.12.2015	Defer Date:
	Decision:Application awaited from RLA,Moradabad.

---|---|---|---| ||HQ File :01/82/050/02487/AM19/|RLA File :29/21/040/00029/AM16/|Lic.No/Date:2910025235 21.12.2015|Defer Date:| ||**Decision:**Application awaited from RLA,Moradabad.||||

Case No.:410/15/82-	Party Name:TATVA	Meet No/Date:15/82-	Status:
ALC4/2018	CHINTAN PHARMA CHEM	ALC4/2018	Approved
	PVT LTD	22.03.2019
HQ File	RLA File	Lic.No/Date:3410041759	Defer Date:
:01/82/050/01867/AM19/	:34/24/040/00241/AM16/	23.12.2015

	Case No.:410/15/82-<br>ALC4/2018	Case No.:410/15/82-<br>ALC4/2018	Party Name:TATVA<br>CHINTAN PHARMA CHEM<br>PVT LTD	Party Name:TATVA<br>CHINTAN PHARMA CHEM<br>PVT LTD	Party Name:TATVA<br>CHINTAN PHARMA CHEM<br>PVT LTD	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:3410041759<br>23.12.2015	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:3410041759<br>23.12.2015	Status:<br>Approved<br>Defer Date:
	HQ File<br>:01/82/050/01867/AM19/		RLA File<br>:34/24/040/00241/AM16/
70	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>METHOXY METHYL<br>TRIPHENYL<br>PHOSPHONIUM<br>CHLORIDE<br>CAS No.

as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. METHOXY METHYL TRIPHENYL PHOSPHONIUM CHLORIDE CAS No. 4009-98-7 ASSAY NLT 98% 1 kg 1 TRIPHENYL PHOSPHINE CAS NO: 603-35-0 ASSAY NLT 98% 0.806 kg 2 METHYLAL CAS NO. 109-87-5 ASSAY NLT 99% 0.233 kg RA concerned maytake further necessaryaction asper above decision of NC.|||||||| ||Export product|Qty.||Sl. No.|Import items||Qty.|| ||METHOXY METHYL TRIPHENYL PHOSPHONIUM CHLORIDE CAS No. 4009-98-7 ASSAY NLT 98%|1 kg||1|TRIPHENYL PHOSPHINE CAS NO: 603-35-0 ASSAY NLT 98%||0.806 kg|| |||||2|METHYLAL CAS NO. 109-87-5 ASSAY NLT 99%||0.233 kg|| ||RA concerned maytake further necessaryaction as||||per above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:988/15/82-	Party Name:UMA	Meet No/Date:15/82-	Status:
ALC4/2018	ENTERPRISE	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136786	Defer Date:
:01/82/050/02445/AM19/	:08/24/040/00322/AM16/	28.12.2015

---| |ALC4/2018||ENTERPRISE||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0810136786||Defer Date:| |:01/82/050/02445/AM19/||:08/24/040/00322/AM16/||28.12.2015|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 6/82-ALC4/2018, dated 26.07.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 71 applied by firm whichever is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
META CHLOROPER<br>BENZOIC ACID	1 kg	1	META CHLORO BENZOYL<br>CHLORIDE	1.00 kg
		2	TERTIARY BUTANOL	0.50 kg

Case No.:214/15/82-	Party Name:SWISS	Meet No/Date:15/82-	Status:
ALC4/2018	PARENTERALS PVT.LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810136913	Defer Date:
:01/82/050/01671/AM19/	:08/24/040/00334/AM16/	31.12.2015

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 7/82-ALC4/2018, dated 24.08.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 72 applied by firm whichever is lower:

s Meeting No. 7/82-ALC4/2018, dated 24.08.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 72 applied by firm whichever is lower:

Export product	Qty.	Sl.<br>No.	Import items	Qty.
CEFEPIME FOR INJECTION<br>USP/BP/EP/IP 1GM	1 Number	1	RELEVANT BULK DRUG<br>CEFEPIME HCL + L-<br>ARGININE EP/BP/USP/IP	1.8975<br>gram / vial

73	Case No.:215/15/82-<br>ALC4/2018	Party Name:DISHMAN<br>PHARMACEUTICALS &<br>CHEMICALS LTD<br>RLA File<br>:08/24/040/00132/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01672/AM19/		Lic.No/Date:0810136941<br>05.01.2016	Defer Date:
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Ahmedabad.

Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

Case No.:216/15/82-	Party Name:ADVANCE	Meet No/Date:15/82-	Status:
ALC4/2018	PETROCHEMICALS	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0810136962	Defer Date:
:01/82/050/01673/AM19/	:08/24/040/00295/AM16/	06.01.2016

4/2018**||PETROCHEMICALS||ALC4/2018||Approved| |||LIMITED||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0810136962||Defer Date:| |:01/82/050/01673/AM19/||:08/24/040/00295/AM16/||06.01.2016|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 2/82-ALC4/2018, dated 16.05.2018, it was 74 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export Product	Qty.	Sl. No.	Import items	Qty.
DIETHYLENE GLYCOL<br>MONO METHYL ETHER	1 kg	1	METHANOL	0.280 kg
		2	ETHYLENEOXIDE(EO)	0.748 kg

75	Case No.:494/15/82-<br>ALC4/2018	Party Name:BDR<br>PHARMACEUTICALS<br>INTERNATIONAL PVT. LTD.<br>RLA File<br>:03/94/040/00818/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01951/AM19/		Lic.No/Date:0310801693<br>11.01.2016	Defer Date:
	Decision:RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard<br>application of subject Advance Authorization. Application awaited from RLA,Mumbai.			copy of 4.07

**Decision:**RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard application of subject Advance Authorization. Application awaited from RLA,Mumbai.|||copy of 4.07|

76	Case No.:1070/15/82-<br>ALC4/2018	Party Name:NUTRA<br>SPECIALITIES PVT. LTD.,<br>RLA File<br>:04/24/040/00212/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02527/AM19/		Lic.No/Date:0410161506<br>12.01.2016	Defer Date:
	Decision:RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard<br>application of subject Advance Authorization. Application awaited from RLA,Chennai.			copy of 4.07

Decision: RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Chennai.

Case No.:990/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109274	Defer Date:
:01/82/050/02447/AM19/	:07/24/040/00335/AM16/	18.01.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710109274||Defer Date:| |:01/82/050/02447/AM19/||:07/24/040/00335/AM16/||18.01.2016|||

	Case No.:990/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02447/AM19/	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
		RLA File<br>:07/24/040/00335/AM16/	Lic.No/Date:0710109274<br>18.01.2016	Defer Date:
77	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>Neulin 125mg Tablets -<br>Theophylline 125 Mg<br>+Guar gum 4.375 Mg<br>(Theop-1000.000<br>+GUAR.GUM 35.000<br>KGS) (No. of Tabs -<br>8000000)<br>1 no. of<br>Neulin Tablet<br>1.<br>Theophylline BP / EP / USP / PH.EUR<br>Anhydrous Powder<br>127.5 mg<br>2.<br>Guar Gum IH (BP / EP / USP /<br>PH.EUR)<br>4.375 mg<br>Neulin 200mg Tablets -<br>Theophylline 200 Mg +<br>Guar gum 7.00 Mg<br>(Theop-<br>1857.143+GUAR.GUM<br>65.000 KGS) (No. of<br>Tabs - 9285714)<br>1 no.

um IH (BP / EP / USP / PH.EUR) 4.375 mg Neulin 200mg Tablets - Theophylline 200 Mg + Guar gum 7.00 Mg (Theop- 1857.143+GUAR.GUM 65.000 KGS) (No. of Tabs - 9285714) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 204.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 7.00 mg Neulin 250mg Tablets - Theophylline 250 Mg + Guar gum 8.750 Mg (Theop- 2000.000+GUAR.GUM 70.000 KGS) (No. of Tabs - 8000000) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 255.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 8.75 mg Neulin 300mg Tablets - Theophylline 300 Mg + Guar gum 10.5 Mg (Theop- 2571.429+GUAR.GUM 90.000 KGS) (No. of Tabs - 8571429) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 306.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:991/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109276	Defer Date:
:01/82/050/02448/AM19/	:07/24/040/00340/AM16/	18.01.2016


<br> <br> <br>:	Case No.:991/15/82-<br>ALC4/2018	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
		INGRAM LTD,	ALC4/2018<br>22.03.2019	Approved
	HQ File<br>01/82/050/02448/AM19/	RLA File<br>:07/24/040/00340/AM16/	Lic.No/Date:0710109276<br>18.01.2016	Defer Date:
<br>t<br> <br>	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>he light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

al Experts and in he light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. Neulin 125mg Tablets - 1 no of 1 Theophlline BP / EP / USP / 1275 mg|||||||||| |||Qty.||Sl. No.|Import items|||Qty.||| |||1 no of||1|Theophlline BP / EP / USP /|||1275 mg||| || Theophylline 125 Mg +Gar m 4375 M|. Neulin Tablet||.|y PH.EUR Anhydrous Powder|||.||| |||||2.|Guar Gum IH (BP / EP / USP /|||4.375 mg||| |78|u gu . g (Theop-1000.000 +GUAR.GUM 35.000 KGS N f Tb|||| PH.EUR)| ||||| ||) (o. o as - 8000000)|||||||||| ||Neulin 200mg Tablets - Theophylline 200 Mg + Guar gum 7.00 Mg (Theop- 1857.143+GUAR.GUM 65.000 KGS) (No. of Tabs - 9285714) Neulin 250mg Tablets - Theophylline 250 Mg +|1 no. of neulin tablet||1|Theophylline BP / EP / USP / PH.EUR Anhydrous Powder|||204.0 mg||| |||||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||7.00 mg||| |||1 no. of neulin tablet||1|Theophylline BP / EP / USP / PH.EUR Anhydrous Powder|||255.0 mg||| || Guar gum 8.750 Mg (Theop-|||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||8.75 mg||| ||2000.000+GUAR.GUM 70.000 KGS) (No. of Tabs - 8000000)|||||||||| || Neulin 300mg Tablets -|||||||||| |||1 n|o.

m 8.750 Mg (Theop-|||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||8.75 mg||| ||2000.000+GUAR.GUM 70.000 KGS) (No. of Tabs - 8000000)|||||||||| || Neulin 300mg Tablets -|||||||||| |||1 n|o. of|1|Theophyllin||e BP / EP / USP /|30|6.0 mg|| ||Theophylline 300 Mg + |neulin tablet|||PH.EUR Anhydrous Powder|||||| |||||||||||| ||Guar gum 10.5 Mg (Theop- 2571.429+GUAR.GUM 90.000 KGS) (No. of Tabs - 8571429) 2 Guar Gum IH (BP / EP / USP / PH.EUR) RA concerned maytake further necessaryaction asper above decision of NC.|||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||10.5 mg|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

	Case No.:267/15/82-	Party Name:BODAL	Meet No/Date:15/82-	Status:
	ALC4/2018	CHEMICALS LTD	ALC4/2018	Deferred
			22.03.2019
79	HQ File	RLA File	Lic.No/Date:0810137048	Defer Date:
	:01/82/050/01724/AM19/	:08/24/040/00341/AM16/	22.01.2016
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Ahmedabad.

:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard||||||copy of 4.07| |||application of subject Advance Authorization. Application awaited||||from RLA,Ahmedabad.|||

Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

	Case No.:278/15/82-	Party Name:HETERO LABS	Meet No/Date:15/82-	Status:
	ALC4/2018	LIMITED	ALC4/2018	Deferred
			22.03.2019
80	HQ File	RLA File	Lic.No/Date:0910063155	Defer Date:
	:01/82/050/01735/AM19/	:09/24/040/00618/AM16/	22.01.2016
	Decision:RLA, Hyderabadwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Hyderabad.

	Case No.:213/15/82-	Party Name:POLYGON	Meet No/Date:15/82-		Status:
	ALC4/2018	CHEMICALS	ALC4/2018		Deferred
			22.03.2019
81	HQ File	RLA File	Lic.No/Date:0810137119		Defer Date:
	:01/82/050/01670/AM19/	:08/24/040/00370/AM16/	03.02.2016
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Ahmedabad.

:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard|||||copy of 4.07|| |||application of subject Advance Authorization. Application awaited||||from RLA,Ahmedabad.|||

Case No.:273/15/82-	Party Name:POSY	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACHEM PVT. LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810137117	Defer Date:
:01/82/050/01730/AM19/	:08/24/040/00377/AM16/	03.02.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2013, dated 02.05.2013, it was 82 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Exportproduct	Qty.	Sl. No.	Import items	Qty.
SODIUM CITRATE BP / USP	1 kg	1	CAUSTIC SODA FLACKS /	0.736 kg
			PEARLS
		2.	CITRIC ACID MONO	0.421 kg
			HYDRATE

Case No.:217/15/82-	Party Name:DIVIS	Meet No/Date:15/82-	Status:Approved
ALC4/2018	LABORATORIES LTD.,	ALC4/2018
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910063228	Defer Date:
:01/82/050/01674/AM19/	:09/24/040/00641/AM16/	08.02.2016

---|---| |ALC4/2018||LABORATORIES LTD.,||ALC4/2018||| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0910063228||Defer Date:| |:01/82/050/01674/AM19/||:09/24/040/00641/AM16/||08.02.2016|||

Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied 83 by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
NABUMETONE	20000.00 kg	1	2-ACETYL-6-METHOXY NAPHTHALENE	40000.00 kg
		2	METHANOL	130800.00 kg

	Case No.:260/15/82-	Party Name:VINNY	Meet No/Date:15/82-		Status:
	ALC4/2018	HEALTHCARE PRIVATE	ALC4/2018		Deferred
		LIMITED	22.03.2019
84	HQ File	RLA File	Lic.No/Date:0810137198		Defer Date:
	:01/82/050/01717/AM19/	:08/24/040/00386/AM16/	12.02.2016
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Ahmedabad.

:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard|||||copy of 4.07|| |||application of subject Advance Authorization. Application awaited||||from RLA,Ahmedabad.|||

	Case No.:218/15/82-	Party Name:VIRCHOW	Meet No/Date:15/82-		Status:
	ALC4/2018	PETROCHEMICAL PVT LTD.	ALC4/2018		Deferred
			22.03.2019
85	HQ File	RLA File	Lic.No/Date:0910063299		Defer Date:
	:01/82/050/01675/AM19/	:09/24/040/00655/AM16/	19.02.2016
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Ahmedabad.

	Case No.:272/15/82-	Party Name:BODAL	Meet No/Date:15/82-		Status:
	ALC4/2018	CHEMICALS LIMITED	ALC4/2018		Deferred
			22.03.2019
86	HQ File	RLA File	Lic.No/Date:0810137264		Defer Date:
	:01/82/050/01729/AM19/	:08/24/040/00394/AM16/	23.02.2016
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited		from RLA,Ahmedabad.

:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard|||||copy of 4.07|| |||application of subject Advance Authorization. Application awaited||||from RLA,Ahmedabad.|||

87	Case No.:996/15/82-<br>ALC4/2018	Party Name:RECKITT<br>BENCKISER ( INDIA) LTD	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred<br>Defer Date:
	HQ File<br>:01/82/050/02453/AM19/	RLA File<br>:07/24/040/00374/AM16/	Lic.No/Date:0710109433<br>23.02.2016
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.

Case No.:997/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109438	Defer Date:
:01/82/050/02454/AM19/	:07/24/040/00379/AM16/	24.02.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710109438||Defer Date:| |:01/82/050/02454/AM19/||:07/24/040/00379/AM16/||24.02.2016|||

<br>	Case No.:997/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD	Party Name:ADCOCK<br>INGRAM LTD	Party Name:ADCOCK<br>INGRAM LTD	Meet No/Date:15/82-<br>ALC4/2018	Meet No/Date:15/82-<br>ALC4/2018	Status:<br>Aroved
<br> <br>		,<br>RLA File<br>:07/24/040/00379/AM16/			<br>22.03.2019		pp
	HQ File<br>:01/82/050/02454/AM19/				Lic.No/Date:07101094<br>24022016	38	Defer Date:
					..
88<br> <br> <br> <br>	Decision:The Committee co<br>th liht f li dii tk	nsidered the case as per agenda<br>b NC i it Mti N		in the presence of Techni<br>3/82ALC4/2014 dtd		cal Experts and in<br>8052014 it
	e g o earer ecson aen y<br>decided to ratify the ad-hoc input output<br>applied by firm whichever is lower:		n s eeng o. -, ae .., was<br>norms under para 4.7 of HBP Vol. I as per details below or as<br>Sl.No.<br>Import items<br>Qty.<br>1.<br>DOXYLAMINE SUCCINATE<br>USP /Ph.

ed by firm whichever is lower:||n s eeng o. -, ae .., was norms under para 4.7 of HBP Vol. I as per details below or as Sl.No. Import items Qty. 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR QUINOLINE YELLOW WS (SPECTRACOL) 4.56 kg|||||||| ||Exportproduct|Qty.|Sl.No.|Import items||||Qty.||| ||ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg +Colour Yellow Lake-|1 million tablets|1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||||5.10 kg||| ||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||||10.2 kg||| ||||3.|COLOUR QUINOLINE YELLOW WS (SPECTRACOL)||||4.56 kg||| ||4.56mg Colour Yellow WS- 2.43mg Tablets (Para -|||||||||| ||9450.000 +Codeine - 210.000 + Caff -945.000+ Doxy-105.000+Colour Yellow WS-51.030+Colour Yellow Lake-95.760 KGS)|||||||||| |||||||||||| ||(No. of Tablets 21000000)|||||||||| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||||| ||||||||||||

Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:998/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109439	Defer Date:
:01/82/050/02455/AM19/	:07/24/040/00381/AM16/	24.02.2016

	Case No.:998/15/82-<br>ALC4/2018	Case No.:998/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02455/AM19/		RLA File<br>:07/24/040/00381/AM16/			Lic.No/Date:0710109439<br>24.02.2016		Defer Date:
89	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Exportproduct<br> Qty.<br>Sl.

d 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Exportproduct Qty. Sl. No. Import items Qty. ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg+ Colour Yellow Lake-4.56mg Colour Yellow WS-2.43mg Tablets (Para -22500.000 +Codeine - 500.000 + Caff - 2250.000+ Doxy- 250.000+Colour Yellow WS-121.500+Colour Yellow Lake-228.000 KGS) (No. of Tablets 50000000) 1 million tablets 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR QUINOLINE YELLOW WS (SPECTRACOL) 4.56 kg RA concerned maytake further necessaryaction asper above decision of NC.|||||||| ||Exportproduct|Qty.||Sl. No.|Import items||Qty.|| ||ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg+ Colour Yellow Lake-4.56mg Colour Yellow WS-2.43mg Tablets (Para -22500.000 +Codeine - 500.000 + Caff - 2250.000+ Doxy- 250.000+Colour Yellow WS-121.500+Colour Yellow Lake-228.000 KGS) (No. of Tablets 50000000)|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg|| |||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg|| |||||3.|COLOUR QUINOLINE YELLOW WS (SPECTRACOL)||4.56 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

IENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg|| |||||3.|COLOUR QUINOLINE YELLOW WS (SPECTRACOL)||4.56 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:999/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109441	Defer Date:
:01/82/050/02456/AM19/	:07/24/040/00380/AM16/	24.02.2016

	Case No.:999/15/82-<br>ALC4/2018	Case No.:999/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02456/AM19/		RLA File<br>:07/24/040/00380/AM16/			Lic.No/Date:0710109441<br>24.02.2016		Defer Date:
90	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No.

r>24.02.2016||Defer Date:| |90|**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2014, dated 08.05.2014, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Exportproduct Qty. Sl.No. Import items Qty. ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg +Colour Yellow Lake- 4.56mg Colour Yellow WS- 2.43mg Tablets (Para - 9450.000 +Codeine - 210.000 + Caff -945.000+ Doxy-105.000+Colour Yellow WS-51.030+Colour Yellow Lake-95.760 KGS) (No. of Tablets 21000000) 1 million tablets 1. DOXYLAMINE SUCCINATE USP /Ph. Eur Grade 5.10 kg 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg 3. COLOUR QUINOLINE YELLOW WS (SPECTRACOL) 4.56 kg RA concerned maytake further necessaryaction asper above decision of NC.|||||||| ||Exportproduct|Qty.||Sl.No.|Import items||Qty.|| ||ADCO DOL TABS - (Paracetamol 450mg + Codeine Phosphate 10mg+ Caffeine 45mg + Doxylamine Succinate 5mg +Colour Yellow Lake- 4.56mg Colour Yellow WS- 2.43mg Tablets (Para - 9450.000 +Codeine - 210.000 + Caff -945.000+ Doxy-105.000+Colour Yellow WS-51.030+Colour Yellow Lake-95.760 KGS) (No. of Tablets 21000000)|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph.

deine - 210.000 + Caff -945.000+ Doxy-105.000+Colour Yellow WS-51.030+Colour Yellow Lake-95.760 KGS) (No. of Tablets 21000000)|1 million tablets||1.|DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg|| |||||2.|CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg|| |||||3.|COLOUR QUINOLINE YELLOW WS (SPECTRACOL)||4.56 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:1005/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109472	Defer Date:
:01/82/050/02462/AM19/	:07/24/040/00395/AM16/	03.03.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710109472||Defer Date:| |:01/82/050/02462/AM19/||:07/24/040/00395/AM16/||03.03.2016|||

	Case No.:1005/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/02462/AM19/	RLA File<br>:07/24/040/00395/AM16/	Lic.No/Date:0710109472<br>03.03.2016	Defer Date:
91	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2018, dated 05.06.2018, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.No.<br>Import items<br>Qty.<br>CAL - SUP TABLETS<br>(CALCIUM CARBONATE<br>1250 MG + GLYCINE<br>535.7 MG)<br>(Glycine - 3000.000 KGS +<br>Calcium - 7000.187 KGS)<br>(No of Tabs-5600149)<br>1<br>Number<br>1<br>GLYCINE USP/BP/EP<br>535.7 mg/tablet<br>2<br>CALCIUM CARBONATE<br>DENSE BP/USP<br>1275 mg/tablet<br>RA concerned maytake further necessaryaction asper above decision of NC.

1 Number 1 GLYCINE USP/BP/EP 535.7 mg/tablet 2 CALCIUM CARBONATE DENSE BP/USP 1275 mg/tablet RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2018, dated 05.06.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:424/15/82-	Party Name:ENVEE DRUGS	Meet No/Date:15/82-	Status:
ALC4/2018	PVT LTD	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:3410041948	Defer Date:
:01/82/050/01881/AM19/	:34/24/040/00327/AM16/	08.03.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was 92 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
BETAMETHASONE DI PROPIONATE	1 kg	1	BETAMETHASONE	0.868 kg
BP/USP			EP/BP/IP/USP

by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
BETAMETHASONE DI PROPIONATE	1 kg	1	BETAMETHASONE	0.868 kg
BP/USP			EP/BP/IP/USP

Case No.:425/15/82-	Party Name:ENVEE DRUGS	Meet No/Date:15/82-	Status:
ALC4/2018	PVT LTD	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:3410041949	Defer Date:
:01/82/050/01882/AM19/	:34/24/040/00328/AM16/	08.03.2016

		ALC4/2018<br>PVT LTD<br>ALC4/2018<br>22.03.2019<br>Approved<br>HQ File<br>:01/82/050/01882/AM19/<br>RLA File<br>:34/24/040/00328/AM16/<br>Lic.No/Date:3410041949<br>08.03.2016<br>Defer Date:	ALC4/2018<br>PVT LTD<br>ALC4/2018<br>22.03.2019<br>Approved<br>HQ File<br>:01/82/050/01882/AM19/<br>RLA File<br>:34/24/040/00328/AM16/<br>Lic.No/Date:3410041949<br>08.03.2016<br>Defer Date:	ALC4/2018<br>PVT LTD<br>ALC4/2018<br>22.03.2019<br>Approved<br>HQ File<br>:01/82/050/01882/AM19/<br>RLA File<br>:34/24/040/00328/AM16/<br>Lic.No/Date:3410041949<br>08.03.2016<br>Defer Date:	ALC4/2018<br>PVT LTD<br>ALC4/2018<br>22.03.2019<br>Approved<br>HQ File<br>:01/82/050/01882/AM19/<br>RLA File<br>:34/24/040/00328/AM16/<br>Lic.No/Date:3410041949<br>08.03.2016<br>Defer Date:	ALC4/2018<br>PVT LTD<br>ALC4/2018<br>22.03.2019<br>Approved<br>HQ File<br>:01/82/050/01882/AM19/<br>RLA File<br>:34/24/040/00328/AM16/<br>Lic.No/Date:3410041949<br>08.03.2016<br>Defer Date:

LC4/2018 22.03.2019 Approved HQ File :01/82/050/01882/AM19/ RLA File :34/24/040/00328/AM16/ Lic.No/Date:3410041949 08.03.2016 Defer Date:| |---|---|---|---|---|---|---| |||**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and in||||| |||the light of earlier decision taken by||NC in its Meeting No. 4/82-ALC4/2018, dated 19.06.2018, it was||| |93||decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as||||| |||applied by firm whichever is lower:||||| ||||Export product|Qty. Sl. Import items|Qty.|| |||||No.||| ||||BETAMETHASONE VALERATE|1 kg 1 BETAMETHASONE EP/BP/IP/USP|0.915 kg|| ||||BP/USP|||| |||RA concerned maytake further necessaryaction asper above decision of NC.|||||

	Case No.:1000/15/82-		Party Name:KARNATAKA	Meet No/Date:15/82-	Status:
	ALC4/2018		ANTIBIOTICS &	ALC4/2018	Deferred
			PHARMACEUTICALS LTD.,	22.03.2019
94	HQ File		RLA File	Lic.No/Date:0710109509	Defer Date:
	:01/82/050/02457/AM19/		:07/24/040/00393/AM16/	10.03.2016
	Decision:RLA, Bangalore	was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance	Authorization. Application awaited		from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

	Case No.:304/15/82-	Party Name:STERILE INDIA		Meet No/Date:15/82-	Status:
	ALC4/2018	PRIVATE LIMITED		ALC4/2018	Deferred
				22.03.2019
95	HQ File	RLA File		Lic.No/Date:0510397954	Defer Date:
	:01/82/050/01761/AM19/	:05/24/040/00600/AM16/		17.03.2016
	Decision:CLA, New Delhiwas requested vide e-mail dated		05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from CLA,New Delhi.

Decision: CLA, New Delhiwas requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from CLA, New Delhi.

Case No.:317/15/82-	Party Name:DR. REDDYS	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910063425	Defer Date:
:01/82/050/01774/AM19/	:09/24/040/00708/AM16/	17.03.2016

C4/2018**||LABORATORIES LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0910063425||Defer Date:| |:01/82/050/01774/AM19/||:09/24/040/00708/AM16/||17.03.2016|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2015, dated 20.05.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: 96

Export product	Qty	Sl.	Import items	Qty
		No.
2-(6-Methoxy-2-	1kg	1	2-Acetyl-6-Methoxy Naphthalene	1.04 kg
Naphthyl)<br>Propionic<br>Acid (DL Acid)		2<br>3	Hydroxylamine Sulphate<br>Activated Carbon (SC 40 Grade)	0.48kg<br>0.04kg
		4	Caustic Potash Flakes	1.14kg

Case No.:431/15/82-	Party Name:RONAK	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICALS	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:3410041987	Defer Date:
:01/82/050/01888/AM19/	:34/24/040/00341/AM16/	17.03.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was 97 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was 97 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl. No.	Import items	Qty.
BARBITURIC ACID	1 kg	1	DIETYL MALONATE	1.46 kg

	Case No.:1006/15/82-		Party Name:STELLENCE		Meet No/Date:15/82-	Status:
	ALC4/2018		PHARMSCIENCE PVT LTD		ALC4/2018	Deferred
					22.03.2019
98	HQ File		RLA File		Lic.No/Date:0710109590	Defer Date:
	:01/82/050/02463/AM19/		:07/24/040/00420/AM16/		29.03.2016
	Decision:RLA, Bangalore	was requested vide e-mail dated		05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance	Authorization. Application awaited from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

Decision:* RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

99<br> <br> <br> <br> <br> <br>	Case No.:219/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/01676/AM19/	Party Name:VIRCHOW<br>PETROCHEMICAL PVT LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
		RLA File<br>:09/24/040/00753/AM16/	Lic.No/Date:0910063474<br>31.03.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

100	Case No.:220/15/82-<br>ALC4/2018	Party Name:DR. REDDYS<br>LABORATORIES LIMITED<br>RLA File<br>:09/24/040/00768/AM16/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/01677/AM19/		Lic.No/Date:0910063493<br>05.04.2016
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

Case No.:235/15/82-	Party Name:R L FINE CHEM	Meet No/Date:15/82-	Status:
ALC4/2018		ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710109995	Defer Date:
:01/82/050/01692/AM19/	:07/24/040/00058/AM17/	24.06.2016

Qty.	Sl.<br>No.	Import items	Qty.<br> <br>0.85 kg<br>0.91 kg
<br>1 kg	1	1 BROMO 3 CHLORO PROPANE
	2	3 CHLORO IMINODIBENZYL

Case No.:236/15/82-	Party Name:JUBILANT LIFE	Meet No/Date:15/82-	Status:
ALC4/2018	SCIENCES LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510398907	Defer Date:
:01/82/050/01693/AM19/	:05/23/040/00055/AM17/	24.06.2016

ALC4/2018||SCIENCES LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0510398907||Defer Date:| |:01/82/050/01693/AM19/||:05/23/040/00055/AM17/||24.06.2016|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 4/82-ALC4/2018, dated 19.06.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 128 applied by firm whichever is lower:

Exportproduct	Qty.	Sl.No.	Import items	Qty.
Gamma Picoline	1 kg	1	Denatured Ethyl Alcohol	1.60 kg
		2	Ammonia	0.40 kg
		3	Alumino Silicate Catalyst	0.002 kg

Case No.:237/15/82-	Party Name:RAY	Meet No/Date:15/82-	Status:
ALC4/2018	CHEMICALS PRIVATE	ALC4/2018	Approved
	LIMITED,	22.03.2019
HQ File	RLA File	Lic.No/Date:0710110003	Defer Date:
:01/82/050/01694/AM19/	:07/24/040/00062/AM17/	27.06.2016

Qty.	Sl.<br>No.	Import items	Qty.
1 kg	1	1 BROMO 3 CHLORO PROPANE	0.92 kg
	2	TETRA HYDRO FURAN	0.50 kg
	3	THIOPHENOL	0.65 kg
	4	ACETONE	0.50 kg

er is lower: 129

Qty.	Sl.<br>No.	Import items	Qty.
1 kg	1	1 BROMO 3 CHLORO PROPANE	0.92 kg
	2	TETRA HYDRO FURAN	0.50 kg
	3	THIOPHENOL	0.65 kg
	4	ACETONE	0.50 kg

Case No.:397/15/82-	Party Name:SONGWON	Meet No/Date:15/82-	Status:
ALC4/2018	SPECIALTY CHEMICALS	ALC4/2018	Approved
	INDIA PVT. LTD.	22.03.2019
HQ File	RLA File	Lic.No/Date:341004234	Defer Date:
:01/82/050/01854/AM19/	:34/24/040/00104/AM17/	1
		08.07.2016

	Case No.:397/15/82-<br>ALC4/2018	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/01854/AM19/	RLA File<br>:34/24/040/00104/AM17/	Lic.No/Date:341004234<br>1<br>08.07.2016	Defer Date:
130	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:238/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110081	Defer Date:
:01/82/050/01695/AM19/	:07/24/040/00123/AM17/	12.07.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710110081||Defer Date:| |:01/82/050/01695/AM19/||:07/24/040/00123/AM17/||12.07.2016|||

	Case No.:238/15/82-<br>ALC4/2018	Party Name:ADCOCK<br>INGRAM LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved<br> <br>Defer Date:
	HQ File<br>:01/82/050/01695/AM19/	RLA File<br>:07/24/040/00123/AM17/	Lic.No/Date:0710110081<br>12.07.2016
131	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>Neulin 125mg<br>Tablets -<br>(Theophylline 125mg<br>+Guar gum 4.375mg)<br>(Theop-1000.000<br>+GUAR GUM<br>35.000 KGS) (No. of<br>Tablets - 8000000)<br>1 no. of<br>Neulin<br>Tablet<br>1.<br>Theophylline BP / EP / USP /<br>PH.EUR Anhydrous Powder<br>127.5 mg<br>2.<br>Guar Gum IH (BP / EP / USP /<br>PH.EUR)<br>4.375 mg<br>Neulin 200mg<br>Tablets -<br>(Theophylline 200mg<br>+ Guar gum 7.00mg)<br>(Theop-<br>1857.143+GUAR<br>GUM 65.000 KGS)<br>(No. of Tablets -<br>9285714)<br>1 no.

/ EP / USP / PH.EUR) 4.375 mg Neulin 200mg Tablets - (Theophylline 200mg + Guar gum 7.00mg) (Theop- 1857.143+GUAR GUM 65.000 KGS) (No. of Tablets - 9285714) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 204.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 7.00 mg Neulin 250mg Tablets - (Theophylline 250mg + Guar gum 8.750mg) (Theop- 2000.000+GUAR GUM 70.000 KGS) (No. of Tablets - 8000000) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 255.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 8.75 mg Neulin 300mg Tablets - (Theophylline 300mg + Guar gum 10.5mg) (Theop- 2571.429+GUAR GUM 90.000 KGS) (No. of Tablets - 8571429) 1 no. of neulin tablet 1 Theophylline BP / EP / USP / PH.EUR Anhydrous Powder 306.0 mg 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:398/15/82-	Party Name:RIDDHI	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMA	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:3410042347	Defer Date:
:01/82/050/01855/AM19/	:34/24/040/00105/AM17/	13.07.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 6/82-ALC4/2018, dated 26.07.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 132 applied by firm whichever is lower:

Exportproduct	Qty.	Sl.No.	Import items		Qty.
1, 3, DICHLORO ACETONE	1 kg	1	1,<br>3,<br>DICHLORO	2-	1.069 kg
			PROPANOL
		2	SODIUM DICHROMATE		1.700 kg

133	Case No.:270/15/82-<br>ALC4/2018	Party Name:ARKRAY<br>HEALTHCARE PVT.LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01727/AM19/	RLA File<br>:52/24/040/00025/AM17/	Lic.No/Date:5210041960<br>14.07.2016	Defer Date:
	Decision:RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Surat.

e:| ||**Decision:**RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Surat.||||

Decision: RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Surat.

Case No.:544/15/82-	Party Name:ZIM	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0310806271	Defer Date:
:01/82/050/02001/AM19/	:03/95/040/00283/AM17/	14.07.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 12/82-ALC4/2018, dated 12.12.2018, it was 134 decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
Azithromycin fororalsuspension 200mg	1 kg	1	Azithromycin IP/USP	0.078kg

Case No.:257/15/82-	Party Name:SUN	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICAL	ALC4/2018	Approved
	INDUSTRIES LTD.,	22.03.2019
HQ File	RLA File	Lic.No/Date:0510399114	Defer Date:
:01/82/050/01714/AM19/	:05/24/040/00162/AM17/	15.07.2016

|PHARMACEUTICAL||ALC4/2018||Approved| |||INDUSTRIES LTD.,||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0510399114||Defer Date:| |:01/82/050/01714/AM19/||:05/24/040/00162/AM17/||15.07.2016|||

	Decision:The Committee considered case as per agenda	Decision:The Committee considered case as per agenda	in the presence of the technical experts and it	in the presence of the technical experts and it	in the presence of the technical experts and it
	was decided to ratify the ad-hoc input output	norms under	para 4.7 of HBP as per details below or as
	applied by firm whichever is lower:
	Export product	Qty.	Sl.	Import items	Qty.
			No.
135	TIMATIMSUN (Timolol Maleate Long Acting	<br>25452.000	1.	TIMOLOL	1055.109
	Ophthalmic<br>Solution<br>0.5%w/v,<br>5ml)	Number		MALEATE USP	gram
	Each ml contains Timolol Maleate USP 6.83
	mg equivalent to Timolol 5.0 mg (Equivalent
	to 869.186 Gram of Bulk Drug)
	LATONCURE<br>(Latanoprost<br>and<br>Timolol	<br>9677.000
	Maleate Ophthalmic Solution 0.005%w/v /	<br>Number
	0.5%w/v,<br>2.5ml)
	Each ml contains Timolol Maleate USP 6.83
	mg equivalent to Timolol 5.0 mg (Equivalent
	to 165.235 Gram of Bulk Drug)
	RA concerned maytake further necessaryaction asper above		decision of NC.

eate USP 6.83||||||| |||mg equivalent to Timolol 5.0 mg (Equivalent||||||| |||to 165.235 Gram of Bulk Drug)||||||| |||RA concerned maytake further necessaryaction asper above|||decision of NC.||||

	Case No.:477/15/82-	Party Name:STELLENCE	Meet No/Date:15/82-	Status:
	ALC4/2018	PHARMSCIENCE PVT LTD	ALC4/2018	Deferred
			22.03.2019
136	HQ File	RLA File	Lic.No/Date:0710110111	Defer Date:
	:01/82/050/01934/AM19/	:07/24/040/00143/AM17/	15.07.2016
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

	Case No.:240/15/82-	Party Name:VIRCHOW	Meet No/Date:15/82-	Status:
	ALC4/2018	PETROCHEMICAL PVT	ALC4/2018	Deferred
		LTD.	22.03.2019
137	HQ File	RLA File	Lic.No/Date:0910063941	Defer Date:
	:01/82/050/01697/AM19/	:09/24/040/00048/AM17/	18.07.2016
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

138	Case No.:241/15/82-<br>ALC4/2018	Party Name:VIRCHOW<br>PETROCHEMICAL PVT<br>LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	HQ File<br>:01/82/050/01698/AM19/	RLA File<br>:09/24/040/00036/AM17/	Lic.No/Date:0910063942<br>18.07.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:242/15/82-	Party Name:BELOOR BAYIR	Meet No/Date:15/82-	Status:
ALC4/2018	BIOTECH LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110139	Defer Date:
:01/82/050/01699/AM19/	:07/24/040/00126/AM17/	21.07.2016

Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 139 per details below or as applied by firm whichever is lower:

e matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 139 per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
CHONDROITIN SULPHATE(USP)	1455.00 kg	1	CHONDROITIN	1470.00 kg
			SULPHATE

140	Case No.:243/15/82-<br>ALC4/2018	Party Name:VIRCHOW<br>PETROCHEMICAL PVT<br>LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01700/AM19/	RLA File<br>:09/24/040/00081/AM17/	Lic.No/Date:0910063968<br>22.07.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

141	Case No.:244/15/82-<br>ALC4/2018	Party Name:VIRCHOW<br>PETROCHEMICAL PVT<br>LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01701/AM19/	RLA File<br>:09/24/040/00079/AM17/	Lic.No/Date:0910063969<br>22.07.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision:**RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Hyderabad.||||

142	Case No.:245/15/82-<br>ALC4/2018	Party Name:VIRCHOW<br>PETROCHEMICAL PVT<br>LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01702/AM19/	RLA File<br>:09/24/040/00082/AM17/	Lic.No/Date:0910063970<br>22.07.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:1067/15/82-	Party Name:STRIDES	Meet No/Date:15/82-	Status:Approved
ALC4/2018	SHASUN LIMITED	ALC4/2018
		22.03.2019
HQ File	RLA File	Lic.No/Date:0410162131	Defer Date:
:01/82/050/02524/AM19/	:04/24/040/00073/AM17/	22.07.2016

---|---|---| |ALC4/2018||SHASUN LIMITED||ALC4/2018||| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0410162131||Defer Date:| |:01/82/050/02524/AM19/||:04/24/040/00073/AM17/||22.07.2016|||

	Case No.:1067/15/82-<br>ALC4/2018	Case No.:1067/15/82-<br>ALC4/2018	Party Name:STRIDES<br>SHASUN LIMITED	Party Name:STRIDES<br>SHASUN LIMITED	Party Name:STRIDES<br>SHASUN LIMITED	Party Name:STRIDES<br>SHASUN LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:Approved
	HQ File<br>:01/82/050/02524/AM19/		RLA File<br>:04/24/040/00073/AM17/				Lic.No/Date:0410162131<br>22.07.2016	Defer Date:
143	<br>Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 7/82-ALC4/2018, dated 24.08.2018, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.No.<br>Import items<br>Qty.<br>GABAPENTIN TABLETS<br>USP 600 MG (500 PACK)<br>1 Number<br>1<br>GABAPENTIN USP<br>612.00 mg /<br>tablet<br>2<br>Mannitol (Pearlitol<br>100SD) USP/NF<br>91.5 mg/tablet<br>3<br>Copovidone/Plasdone S-<br>630 USP/NF/Ph.Eur<br>30.0 mg /tablet<br>4<br>Kolliphor P 407 Micro<br>1.00 mg/tablet<br>5<br>MAGENSIUM<br>STEARATE VEG.<br>EP/USP / NF<br>2.00 mg/tablet<br>6<br>Hydroxy Propyl Cellulose<br>NF/Ph.Eur( Klucel-EF<br>PH)<br>30.00 mg/tablet<br>7<br>Low substituted Hydroxy<br>Propyl Cellulose USP NF.<br>JP<br>1

STEARATE VEG. EP/USP / NF 2.00 mg/tablet 6 Hydroxy Propyl Cellulose NF/Ph.Eur( Klucel-EF PH) 30.00 mg/tablet 7 Low substituted Hydroxy Propyl Cellulose USP NF. JP 10.00 mg/tablet RA concerned maytake further necessaryaction asper above decision of NC.|||||||| |||Export product||Qty.|Sl.No.|Import items||Qty.| |||GABAPENTIN TABLETS USP 600 MG (500 PACK)||1 Number|1|GABAPENTIN USP||612.00 mg / tablet| ||||||2|Mannitol (Pearlitol 100SD) USP/NF||91.5 mg/tablet| ||||||3|Copovidone/Plasdone S- 630 USP/NF/Ph.Eur||30.0 mg /tablet| ||||||4|Kolliphor P 407 Micro||1.00 mg/tablet| ||||||5|MAGENSIUM STEARATE VEG. EP/USP / NF||2.00 mg/tablet| ||||||6|Hydroxy Propyl Cellulose NF/Ph.Eur( Klucel-EF PH)||30.00 mg/tablet| ||||||7|Low substituted Hydroxy Propyl Cellulose USP NF. JP||10.00 mg/tablet| ||||||sper above decision of NC.||||

144	Case No.:246/15/82-<br>ALC4/2018	Party Name:HONOUR LAB<br>LIMITED	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01703/AM19/	RLA File<br>:09/24/040/00227/AM17/	Lic.No/Date:0910063985<br>26.07.2016	Defer Date:
	Decision:RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Hyderabad.

Decision:**RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Hyderabad.||||

Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad.

Case No.:247/15/82-	Party Name:PORUS	Meet No/Date:15/82-	Status:
ALC4/2018	LABORATORIES PVT LTD	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910063986	Defer Date:
:01/82/050/01704/AM19/	:09/24/040/00237/AM17/	26.07.2016

	Case No.:247/15/82-<br>ALC4/2018	Party Name:PORUS<br>LABORATORIES PVT LTD	Party Name:PORUS<br>LABORATORIES PVT LTD	Party Name:PORUS<br>LABORATORIES PVT LTD	Party Name:PORUS<br>LABORATORIES PVT LTD	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/01704/AM19/	RLA File<br>:09/24/040/00237/AM17/				Lic.No/Date:0910063986<br>26.07.2016		Defer Date:
145	Decision:The Committee considered the cas<br>the light of earlier decision taken by NC in its<br>decided to ratify the ad-hoc input output norm<br>applied by firm whichever is lower:			e as per agenda in the presence of Technical Experts and in<br>Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was<br>s under para 4.7 of HBP Vol.

tput norm applied by firm whichever is lower:|||e as per agenda in the presence of Technical Experts and in Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was s under para 4.7 of HBP Vol. I as per details below or as||||| ||Export product||Qty.|Sl. No.|Import items||Qty.|| ||2-Phenyl-3,3-bis(4-hydroxy phenyl)phthalimide (PPP-BP)||1 kg|1|PTHALIC ANHYDRIDE||0.927 kg|| |||||2|PHENOL||1.145 kg|| |||||3|ZINC CHLORIDE||0.104 kg|| |||||4|ANILINE||0.596 kg|| |||||5|METHANOL||0.715 kg|| |||||6|ACTIVATED CARBON||0.100 kg|| |||||7|CAUSTIC SODA LYE / LIQUID||2.31 kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:478/15/82-	Party Name:BELOOR BAYIR	Meet No/Date:15/82-	Status:
ALC4/2018	BIOTECH LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110226	Defer Date:
:01/82/050/01935/AM19/	:07/24/040/00160/AM17/	08.08.2016

Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 146 per details below or as applied by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
CHONDROITIN SULPHATE(USP)	2910.00 kg	1	CHONDROITIN	2939.10 kg
			SULFATE

pplied by firm whichever is lower:

Export product	Qty.	Sl.	Import items	Qty.
		No.
CHONDROITIN SULPHATE(USP)	2910.00 kg	1	CHONDROITIN	2939.10 kg
			SULFATE

Case No.:1069/15/82-	Party Name:STRIDES	Meet No/Date:15/82-	Status:
ALC4/2018	SHASUN LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0410162178	Defer Date:
:01/82/050/02526/AM19/	:04/24/040/00087/AM17/	09.08.2016

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 1/82-ALC4/2018, dated 01.05.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 147 applied by firm whichever is lower:

Export product	Qty.	Sl.No.	Import items	Qty.
NYSTATIN<br>TABLETS<br>500000UNITS (86.990MG) NET<br>API CONTENT PER TABLET:<br>92.209MG<br>INCLUDING<br>WASTAGE	<br> <br> <br> <br>1 Number	1.	NYSTATIN USP<br>402.365KGS (2748.153<br>BOU)	85.87 mg/tablet

Case No.:248/15/82-	Party Name:SHREE BANKEY	Meet No/Date:15/82-	Status:
ALC4/2018	BEHARI LAL AROMATICS	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510399447	Defer Date:
:01/82/050/01705/AM19/	:05/24/040/00189/AM17/	11.08.2016

C4/2018**||BEHARI LAL AROMATICS||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0510399447||Defer Date:| |:01/82/050/01705/AM19/||:05/24/040/00189/AM17/||11.08.2016|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: 148

Export product	Qty.	Sl.<br>No.	Import items
CARVACROL	1 kg	1	D-LIMONENE (LIMONENE CITRUS<br>TERPENE, ORANGE TERPENE,<br>BRAZILIAN CITRUS TERPENE,<br>STANDARD CITRUS TERPENE,<br>ORANGE OIL)

149	Case No.:485/15/82-<br>ALC4/2018	Party Name:DR. ACHARYA<br>LABORATORIES PVT. LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01942/AM19/	RLA File<br>:03/94/040/00376/AM17/	Lic.No/Date:0310807116<br>12.08.2016	Defer Date:
	Decision:RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Mumbai.

Case No.:249/15/82-	Party Name:ATUL	Meet No/Date:15/82-	Status:
ALC4/2018	BIOSCIENCE LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:5210042005	Defer Date:
:01/82/050/01706/AM19/	:52/24/040/00020/AM17/	18.08.2016

ALC4/2018||BIOSCIENCE LIMITED||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:5210042005||Defer Date:| |:01/82/050/01706/AM19/||:52/24/040/00020/AM17/||18.08.2016|||

Export product	Qty.	Sl.<br>No.	Import items
CBZ-L-VALINE (N-Benzyloxycarbonyl-L-Valine)	1 kg	1	L-VALINE
		2	HEPTANE

151	Case No.:479/15/82-<br>ALC4/2018	Party Name:WINTAC<br>LIMITED,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0710110298<br>22.08.2016	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01936/AM19/	RLA File<br>:07/24/040/00159/AM17/		Defer Date:
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

152	Case No.:495/15/82-<br>ALC4/2018	Party Name:WINTAC<br>LIMITED,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0710110299<br>22.08.2016	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01952/AM19/	RLA File<br>:07/24/040/00165/AM17/		Defer Date:
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

153	Case No.:516/15/82-<br>ALC4/2018	Party Name:BELOOR BAYIR<br>BIOTECH LTD,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/01973/AM19/	RLA File<br>:07/24/040/00182/AM17/	Lic.No/Date:0710110335<br>30.08.2016
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Bangalore.

ion:**RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Bangalore.||||

Case No.:250/15/82-	Party Name:SUN	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICAL	ALC4/2018	Approved
	INDUSTRIES LTD.,	22.03.2019
HQ File	RLA File	Lic.No/Date:0510399650	Defer Date:
:01/82/050/01707/AM19/	:05/24/040/00265/AM17/	08.09.2016

	Case No.:250/15/82-<br>ALC4/2018	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.,	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.,	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.,	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/01707/AM19/	RLA File<br>:05/24/040/00265/AM17/				Lic.No/Date:0510399650<br>08.09.2016		Defer Date:
154	<br>Decision:TheCommittee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as<br>applied by firm whichever is lower:
	<br>Export product		Qty.	Sl.<br>No.	Import items		Qty.

ided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:|||||||| || Export product||Qty.|Sl. No.|Import items||Qty.|| ||Nepafenac Ophthalmic Suspension, 0.1% w/v Nepalact Sterile Eye Drops, 5ml) (PRANAYAM) (Each ml contains Nepafenac 1.0 mg (Equivalent to 118.000 Gram of Bulk Drug)||23600.000 Number|1|NEPAFENAC||120.36 gram|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:251/15/82-	Party Name:HETERO DRUGS	Meet No/Date:15/82-	Status:
ALC4/2018	LIMITED	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910064114	Defer Date:
:01/82/050/01708/AM19/	:09/24/040/00293/AM17/	08.09.2016

155

Export product	Qty.	Sl.<br>No.	Import items
Levofloxacin Hemihydrate	1 kg	1	Ethyl(S)-9,10-difluoro-3-<br>methyl-7-oxo-2,3-dihydro-<br>7H-pyrido(1,2,3-DE)-1,4-<br>benzoxazine-6-carboxylate.

|Sl. No.|Import items| |---|---|---|---| |Levofloxacin Hemihydrate|1 kg|1|Ethyl(S)-9,10-difluoro-3- methyl-7-oxo-2,3-dihydro- 7H-pyrido(1,2,3-DE)-1,4- benzoxazine-6-carboxylate.|

Case No.:253/15/82-	Party Name:ACULIFE	Meet No/Date:15/82-	Status:
ALC4/2018	HEALTHCARE PRIVATE	ALC4/2018	Deferred
	LIMITED,	22.03.2019
HQ File	RLA File	Lic.No/Date:0810138644	Defer Date:
:01/82/050/01710/AM19/	:08/24/040/00158/AM17/	12.09.2016

156 Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

However, it was observed that the li cence has been issued for Soyabean Oil, which comes under restricted category under para 4.6 of HBP Vol. I. Hence it was decided to ask RA, Dehradun to clarify the matter on how the Advance Authorization has been issued.

Case No.:254/15/82-	Party Name:ACULIFE	Meet No/Date:15/82-	Status:
ALC4/2018	HEALTHCARE PRIVATE	ALC4/2018	Deferred
	LIMITED,	22.03.2019
HQ File	RLA File	Lic.No/Date:0810138645	Defer Date:
:01/82/050/01711/AM19/	:08/24/040/00159/AM17/	12.09.2016

157 Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

Case No.:255/15/82-	Party Name:ACULIFE	Meet No/Date:15/82-	Status:
ALC4/2018	HEALTHCARE PRIVATE	ALC4/2018	Deferred
	LIMITED,	22.03.2019
HQ File	RLA File	Lic.No/Date:0810138646	Defer Date:
:01/82/050/01712/AM19/	:08/24/040/00164/AM17/	12.09.2016

158 Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

bean Oil, which comes under restricted category under para 4.6 of HBP Vol. I. Hence it was decided to ask RA, Dehradun to clarify the matter on how the Advance Authorization has been issued.**

		Case No.:555/15/82-<br>Party Name:MEDREICH<br>Meet No/Date:15/82-<br>Status:
		ALC4/2018<br>LIMITED<br>ALC4/2018<br>Approved
		22.03.2019
159		HQ File<br>:01/82/050/02012/AM19/<br>RLA File<br>:07/24/040/00208/AM17/<br>Lic.No/Date:0710110452<br>23.09.2016<br>Defer Date:
		Decision:The Committee considered case as per agenda in the presence of technical experts and
		deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc
		input output norms asper SIONA A- 3648 onpro-rata basis or as applied byfirm whichever is lower.

Decision: The Committee considered case as per agenda in the presence of technical experts and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms as per SIONA A- 3648 on pro-rata basis or as applied by firm whichever is lower.

Case No.:399/15/82-	Party Name:ASTRAL	Meet No/Date:15/82-	Status:
ALC4/2018	STERITECH PVT. LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:3410042562	Defer Date:
:01/82/050/01856/AM19/	:34/24/040/00134/AM17/	28.09.2016

LC4/2018**||STERITECH PVT. LTD.||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:3410042562||Defer Date:| |:01/82/050/01856/AM19/||:34/24/040/00134/AM17/||28.09.2016|||

	Case No:555/15/82-	Part Name:MEDREICH	Part Name:MEDREICH	Part Name:MEDREICH	Meet No/Date:15/82-	Status:
159	.<br>ALC4/2018	y<br>LIMITED			<br>ALC4/2018<br>22.03.2019	<br>Approved<br>Defer Date:
	HQ File	RLA File			LicNo/Date:0710110452
	<br> <br>:01/82/050/02012/AM19/	<br>:07/24/040/00208/AM17/			.<br>23.09.2016
	DiiTh Citt	idd d i			th f thi	t d
	ecson:e ommee consere case as per agena n e presence o ecnca expers an<br>deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc<br>input output norms asper SIONA A- 3648 onpro-rata basis or as applied byfirm whichever is lower.



	Case No.:399/15/82-<br>ALC4/2018	Part<br>STE	y Name:<br>RITEC	ASTRAL<br>H PVT.

r as applied byfirm whichever is lower.||||||||||||||| ||||||||||||||||| ||||||||||||||||| ||||||||||||||||| ||Case No.:399/15/82- ALC4/2018||Part STE|y Name: RITEC||ASTRAL H PVT. LT|||D.|||Meet No/Date:15/82- ALC4/2018 22032019|||Status: Approved| |||||||||||||..|||Defer Date:| ||HQ File 01/82/050/01856/AM19/||RLA File 34/24/040/00134/AM17/|||||||||Lic.No/Date:3410042562 28092016|||| ||:||:|||||||||..|||| ||**Decision:**The Committee considered case as per agenda in the presence of the technical experts and it ||||||||||||||| |160|was decided to ratify the ad-ho applied by firm whichever is low||c input output nor er:|||||ms under para||||4.7 of HBP as per details|||below or as| ||Export product|||Qty.||||Sl.|||Imp|ort items|Qt||y.| ||||||||| No.|||||||| ||Piperacillin Sodium||and|564200.000||||1|||PIP|ERACILLIN|26||65.845 kg| || Tazobactam Sodium Injection 4.5 gm Piperacillin Sodium and Tazobactam Sodium Injection 4.5 gm|||Number|||||||SODIUM AND TAZOBACTAM SODIUM (8:1)(STERILE POWDER) ||||| ||| m|||||||||PIPERACILLIN SODIUM AND||||| |||||||||||| TAZOBACTAM||||| ||||||||||||SODIUM (8:1)(STERILE||||| ||||||||||||POWDER)||||| |||||||||2|||GLASS BOTTLES) || |Relevant as || ||||||||||||ANTIBIOTIC 30 ML CLEAR GLASS TYPE 1|| |per packing li|| |||||||||||| (AS PER GENERAL NOTES)||pocy||| |||||||||||| GLASS BOTTLES) ANTIBIOTIC 30 ML CLEAR GLASS TYPE 1 (AS PER GENERAL NOTES)|||||

|per packing li|| |||||||||||| (AS PER GENERAL NOTES)||pocy||| |||||||||||| GLASS BOTTLES) ANTIBIOTIC 30 ML CLEAR GLASS TYPE 1 (AS PER GENERAL NOTES)||||| |||||||||3|||20MM BROMOBUTYL SERUM STOPPERS V9025 FM257 2 ISAF1 RFS AS PER GENERAL NOTES||Relevant as per packing policy||| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||||||||||

Case No.:566/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110464	Defer Date:
:01/82/050/02023/AM19/	:07/24/040/00214/AM17/	29.09.2016


Case No.:566/15/82-	Party Name:ADCOCK<br>INGRAM LTD,					Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:
ALC4/2018							Approved
HQ File<br>:01/82/050/02023/AM19/	RLA File<br>:07/24/040/00214/AM17/					Lic.No/Date:0710110464<br>29.09.2016	Defer Date:
Decision:The Committee considered the case<br>the light of earlier decision taken by NC in its				as per agenda in the presence of Technical<br>Meeting No. 3/82-ALC4/2014, dated 08.05			Experts and in<br>.2014, it was<br>s below or as
<br>decided to ratify the ad-hoc input outpu<br>applied by firm whichever is lower:		<br>t norm	<br>s	<br>under p	<br>ara 4.7 of HBP Vol.

08.05||||Experts and in .2014, it was s below or as| || decided to ratify the ad-hoc input outpu applied by firm whichever is lower:||| t norm| s| under p| ara 4.7 of HBP Vol. I as per detail|||| |||||||||||| |||||||||||| ||Exportproduct||Qt|y.||Sl.No.||Import items||Qty.| ||SYNDOL TABLETS - (Paracetamol 450mg + Caffeine 30mg + Doxylamine Succinate||1 tab|million lets||1.||DOXYLAMINE SUCCINATE||5.10 kg| |||||||||USP /Ph. Eur Grade||| |||||||2.||CODIENE PHOSPHATE BP /||10.2 kg| ||5mg + Codeine Phosphate 10mg Colour|||||||EP / USP / PH.EUR||| |||||||3||COLOUR YELLOW 14037 IH||1632 k| || Yellow 14037-1.632mg) (Para - 9000.000+Caff -600.000+ Doxy-|||||.||||. g| |161| 100.000+Codeine - 200.000 Colour Yellow 14037-32.640 KGS) (No. of Tablets 2000000| 0)||||||||| || BP/EP/USP/PH.EUR|||||||||| ||ADCO DOL TABLETS -||1 million|||1.||DOX|YLAMINE SUCCINATE|5.10 kg| ||(Paracetamol 450mg+Codeine||tablets|||||USP /Ph. Eur Grade||| ||Phosphate 10mg+Caffeine 45mg+Doxylamine Succinate|||||2.||CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg| ||5mg +Colour Yellow Lake-4.56mg Colour Yellow WS-|+||||3.||COL|OUR YELLOW 14037 IH|2.43 kg| |||||||4.||COL YEL|OUR QUINOLINE LOW WS (SPECTRACOL)|4.56 kg| ||2.43mg)(Para- 31500.000+Codeine-|||||||||| ||700.000+Caff-3150.000+Doxy- |||||||||| ||350.000 Colour Yellow Lake- 319.200 Colour Yellow WS- 170.100 KGS)(No.

LOW WS (SPECTRACOL)|4.56 kg| ||2.43mg)(Para- 31500.000+Codeine-|||||||||| ||700.000+Caff-3150.000+Doxy- |||||||||| ||350.000 Colour Yellow Lake- 319.200 Colour Yellow WS- 170.100 KGS)(No. of Tablets 70000000)BP/EP/USP/PH.EUR|||||||||| ||BETAPYN TABLETS - (Paracetamol 450mg + Caffeine 50mg + Doxylamine Succinate 5mg + Colour Yellow 14037-1.848mg Codeine Phosphate 10mg Tablets (Para -2250.000+ Caff -250.000 Doxy-25.000+Colour Yellow 14037-9.240 Codeine -50.00 KGS (No. of Tablets 5000000) BP / EP / USP / PH.EUR||1 million tablets|||1.||DOXYLAMINE SUCCINATE USP /Ph. Eur Grade||5.10 kg| |||||||2.||CODIENE PHOSPHATE BP / EP / USP / PH.EUR||10.2 kg| |||||||3.||COLOUR YELLOW 14037 IH||Do not match with MBF| ||PYNSTOP TABLETS -||1 million|||1.||DOXYLAMINE SUCCINATE||5.10 kg|

(Paracetamol 450mg + Caffeine 45mg + Doxylamine Succinate 5mg + Codeine Phosphate 10mg Tablets (Para - 2250.000+ Caff -225.000+ Doxy-25.000+Codeine - 50.000 Kgs) (No. of Tablets 5000000) BP / EP / USP / PH.EUR tablets USP /Ph. Eur Grade 2. CODIENE PHOSPHATE BP / EP / USP / PH.EUR 10.2 kg RA concerned maytake further necessaryaction asper above decision of NC.

Case No.:584/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110505	Defer Date:
:01/82/050/02041/AM19/	:07/24/040/00225/AM17/	10.10.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710110505||Defer Date:| |:01/82/050/02041/AM19/||:07/24/040/00225/AM17/||10.10.2016|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 3/82-ALC4/2018, dated 05.06.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as 162 applied by firm whichever is lower:

Export Product<br>CAL - SUP TABLETS<br>(CALCIUM<br>CARBONATE 1250<br>MG + GLYCINE 535.7<br>MG)	Qty.	Sl.No.	Import items	Qty.
	1 Number	1	GLYCINE USP/BP/EP	535.7 mg/tablet
		2	CALCIUM CARBONATE<br>DENSE BP/USP	1275 mg/tablet

163	Case No.:349/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,<br>RLA File<br>:08/24/040/00112/AM17/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Withdrawn
	<br>HQ File<br>:01/82/050/01806/AM19/		Lic.No/Date:0810138894<br>19.10.2016	Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that this licence was<br>issued under Para 4.12 (vi) of HBP Vol. I (2015-20) on the basis of earlier norms fixed by NC-3 in its<br>Meeting No. 12/82-ALC4/2014 dated 19.09.2014(RLA F. No. 08/24/040/00276/AN15). Accordingly, the<br>Committee decided towithdrawthe case.

the basis of earlier norms fixed by NC-3 in its Meeting No. 12/82-ALC4/2014 dated 19.09.2014(RLA F. No. 08/24/040/00276/AN15). Accordingly, the Committee decided towithdrawthe case.||||

164	Case No.:1017/15/82-<br>ALC4/2018	Party Name:EXPO FINE<br>CHEMICAL INDUSTRIES<br>RLA File<br>:24/24/040/00018/AM17/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02474/AM19/		Lic.No/Date:2410042074<br>19.10.2016	Defer Date:
	Decision:The Committee considered the case as per agenda and after deliberations, it wa<br>call for Appendix 4E from the firm. Case is deferred.			s decided to

Decision: The Committee considered the case as per agenda and after deliberations, it was decided to call for Appendix 4E from the firm. Case is deferred.

	Case No.:80/15/82-ALC4/2018	Party Name:AMI ORGANICS	Meet No/Date:15/82-		Status:
		PVT LTD.	ALC4/2018		Deferred
			22.03.2019
165	HQ File	RLA File	Lic.No/Date:5210042053		Defer Date:
	:01/82/050/01537/AM19/	:52/24/040/00045/AM17/	20.10.2016
	Decision:RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard			copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Surat.

Decision: RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Surat.

.|||||||

Decision: RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Surat.

	Case No.:346/15/82-<br>Party Name:ATUL LIMITED,	Meet No/Date:15/82-		Status:
	ALC4/2018	ALC4/2018		Withdrawn
		22.03.2019
	HQ File<br>RLA File	Lic.No/Date:0810138917		Defer Date:
166	:01/82/050/01803/AM19/<br>:08/24/040/00163/AM17/	20.10.2016
	Decision:The Committee considered the case as per agenda and it was observed that this licence was
	issued under Para 4.12 (vi) of HBP Vol. I (2015-20) on the basis of earlier norms fixed		by NC-3 in its
	Meeting No. 12/82-ALC4/2015 dated 18.11.2015 (RLA F. No. 08/24/040/00391/AN15). Accordingly, the
	Committee decided towithdrawthe case.

Decision: The Committee considered the case as per agenda and it was observed that this licence was issued under Para 4.12 (vi) of HBP Vol. I (2015-20) on the basis of earlier norms fixed by NC-3 in its Meeting No. 12/82-ALC4/2015 dated 18.11.2015 (RLA F. No. 08/24/040/00391/AN15). Accordingly, the Committee decided to withdraw the case.

Case No.:557/15/82-	Party Name:ADCOCK	Meet No/Date:15/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0710110547	Defer Date:
:01/82/050/02014/AM19/	:07/24/040/00212/AM17/	20.10.2016

--| |ALC4/2018||INGRAM LTD,||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0710110547||Defer Date:| |:01/82/050/02014/AM19/||:07/24/040/00212/AM17/||20.10.2016|||


	Case No.:557/15/82-<br>ALC4/2018<br> <br>		Party Name:ADCOCK<br>INGRAM LTD,				M<br>A	eet No/Date:15/82-<br>LC4/2018	St<br>A	atus:<br>pproved
	<br> <br>HQ File<br>						<br>2	<br>2.03.2019<br>icNo/Date:0710110547
			RLA File				L		D	fer Date:
	<br>:01/82/050/02014/AM19/<br> <br>		<br>:07/24/040/00212/AM17/				.<br>20.10.2016
	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was
	decided to ratify the ad-hoc inp<br>applied by firm whichever is low<br>		ut output norms under para 4.7 o<br>er:					f HBP Vol. I as per detail		s below or as<br>Qty.
										Qty.
		Export product		Qty.	Sl.<br>No.	Impo		rt items
		Neulin 125mg Tablets -		1 no. of	1.	Theophylline BP / EP / USP /<br>				127.5 mg
		(Theophylline 125mg +Guar gum<br>4.375mg)<br>		Neulin<br>Tablet		PH.EUR Anhydrous Powder
					2.	Guar Gum IH (BP / EP / USP /<br>			4.375 mg
167		(Theop-1000.000 +GUAR GUM<br>35.000 KGS) (No. of Tablets -<br>8000000) BP / EP / USP / PH.EU	<br>R			PH.		UR)

		Neulin 200mg Tablets -<br>(Theophylline 200mg + Guar gu	m	1 no.

167||(Theop-1000.000 +GUAR GUM 35.000 KGS) (No. of Tablets - 8000000) BP / EP / USP / PH.EU| R|||PH.||UR)|||| ||||||||||||| |||Neulin 200mg Tablets - (Theophylline 200mg + Guar gu|m|1 no. of neulin tablet|1|Theo PH.E||phylline BP / EP / USP / UR Anhydrous Powder||204.0 mg|| ||| 7.00mg) |||2|Guar Gum IH (BP / EP / USP / PHEUR||||7.00 mg|| |||(Theop-1857.143+GUAR GUM 65.000 KGS) (No. of Tablets - 9285714) BP / EP / USP / PH.EUR||||.)|||||| |||Neulin 250mg Tablets - (Theophylline 250mg + Guar gum 8.750mg) (Theop-2000.000+GUAR GUM 70.000 KGS) (No. of Tablets - 8000000) BP / EP / USP / PH.EUR||1 no. of neulin tablet|1|Theophylline BP / EP / USP / PH.EUR Anhydrous Powder|||255.0 mg||| ||||||2|Guar Gum IH (BP / EP / USP / PH.EUR)|||8.75 mg||| |||Neulin 300mg Tablets -||1 no. of|1|Theophylline BP / EP / USP / PH.EUR Anhydrous Powder|||306.0 mg|||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 5/82-ALC4/2015, dated 25.06.2015, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:

	(Theophylline 300mg + Guar gum<br>10.5mg)<br>(Theop-2571.429+GUAR GUM<br>90.000 KGS) (No. of Tablets -<br>8571429) BP / EP / USP / PH.EUR<br>neulin tablet<br>2<br>Guar Gum IH (BP / EP / USP /<br>PH.EUR)<br>10.5 mg<br>RA concerned maytake further necessaryaction asper above decision of NC.

BP / EP / USP / PH.EUR neulin tablet 2 Guar Gum IH (BP / EP / USP / PH.EUR) 10.5 mg RA concerned maytake further necessaryaction asper above decision of NC.| |---|---|

Case No.:407/15/82-	Party Name:SONGWON	Meet No/Date:15/82-	Status:
ALC4/2018	SPECIALTY CHEMICALS	ALC4/2018	Approved
	INDIA PVT. LTD.	22.03.2019
HQ File	RLA File	Lic.No/Date:3410042625	Defer Date:
:01/82/050/01864/AM19/	:34/24/040/00208/AM17/	25.10.2016

	Case No.:407/15/82-<br>ALC4/2018	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved	Status:<br>Approved
	HQ File<br>:01/82/050/01864/AM19/	RLA File<br>:34/24/040/00208/AM17/				Lic.No/Date:3410042625<br>25.10.2016		Defer Date:
168	Decision:The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was<br>decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol.

Experts and in the light of earlier decision taken by NC in its Meeting No. 13/82-ALC4/2018, dated 14.01.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. EDOT (3,4 - Ethylenedioxythiophene) 1 kg 1 Dimethyl 2,2 - thiobisacetate 0.566 kg 2 Dimethyl oxalate 1.30 kg 3 Sodium Methoxide Solution 30% (Sodium Methylate) 4.39 kg 4 Dimethylformamide 0.329 kg 5 1,2-Dichloroethane 1.76 kg 6 Sulfolane 0.4186 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||||| ||||Qty.|Sl. No.|Import items|||Qty.|| ||||1 kg|1|Dimethyl 2,2 - thiobisacetate|||0.566 kg|| |||||2|Dimethyl oxalate|||1.30 kg|| |||||3|Sodium Methoxide Solution 30% (Sodium Methylate)|||4.39 kg|| |||||4|Dimethylformamide|||0.329 kg|| |||||5|1,2-Dichloroethane|||1.76 kg|| |||||6|Sulfolane|||0.4186 kg|| |||||per above decision of NC.|||||| ||||||||||| |169 : 4|Case No.:646/15/82- ALC4/2018|Party Name:WINTAC LIMITED, RLA File :07/24/040/00251/AM17/|||||Meet No/Date:15/82- ALC4/2018 22.03.2019||Status: Deferred| ||HQ File 01/82/050/02103/AM19/||||||Lic.No/Date:0710110596 28.10.2016||Defer Date:| ||**Decision:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of .07 application of subject Advance Authorization.

/Date:0710110596 28.10.2016||Defer Date:| ||**Decision:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of .07 application of subject Advance Authorization. Application awaited from RLA,Ahmedabad.|||||||||

Case No.:1018/15/82-	Party Name:CLARION	Meet No/Date:15/82-	Status:Approved
ALC4/2018	ORGANICS LTD.	ALC4/2018
		22.03.2019
HQ File	RLA File	Lic.No/Date:5010002308	Defer Date:
:01/82/050/02475/AM19/	:50/24/040/00011/AM17/	18.11.2016

170

Export product	Qty.	Sl.	Import items	Qty.
		No.
3-METHOXY PROPIOPHENONE	1 kg	1	3-HYDROXY	1.46 kg
( 99% ASSY.VALUE)			BENZOIC ACID
			(99.50%
			ASSY.VALUE)

Case No.:335/15/82-	Party Name:POSY	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACHEM PVT. LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810139051	Defer Date:
:01/82/050/01792/AM19/	:08/24/040/00250/AM17/	22.11.2016

r agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as 171 applied by firm whichever is lower:

Export Product<br>	Qty.	Sl.No.	Import items	Qty.<br>1500.00 kg
CITRIC ACID<br>ANHYDROUS<br>USP/KOSHER<br>	1500.00 kg	1	CITRIC ACID<br>ANHYDROUS

	Case No.:546/15/82-	Party Name:RELIANCE	Meet No/Date:15/82-	Status:
	ALC4/2018	INDUSTRIES LTD.	ALC4/2018	Deferred
			22.03.2019
172	HQ File	RLA File	Lic.No/Date:0310809434	Defer Date:
	:01/82/050/02003/AM19/	:03/95/040/00701/AM16/	30.11.2016
	Decision:The Committee decided to refer the case to Special Committee for further consideration.

	Case No.:559/15/82-	Party Name:RELIANCE	Meet No/Date:15/82-	Status:
	ALC4/2018	INDUSTRIES LTD.	ALC4/2018	Deferred
			22.03.2019
173	HQ File	RLA File	Lic.No/Date:0310809448	Defer Date:
	:01/82/050/02016/AM19/	:03/95/040/00997/AM16/	30.11.2016
	Decision:The Committee decided to refer the case to Special Committee for further consideration.

Case No.:263/15/82-	Party Name:METROCHEM	Meet No/Date:15/82-	Status:
ALC4/2018	API PVT. LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0910064465	Defer Date:
:01/82/050/01720/AM19/	:09/24/040/00465/AM17/	09.12.2016

| |ALC4/2018||API PVT. LTD.||ALC4/2018||Approved| |||||22.03.2019||| |HQ File||RLA File||Lic.No/Date:0910064465||Defer Date:| |:01/82/050/01720/AM19/||:09/24/040/00465/AM17/||09.12.2016|||

Export product	Qty.	Sl.<br>No.	Import items	Qty.
CLOPIDOGREL<br>BISULPHATE	1 kg	1	DL-2-CHLORO PHENYL GLYCINE	1.00 kg
		2	THIOPHENE 2-ETHANOL	0.60 kg

Case No.:264/15/82-	Party Name:JODAS EXPOIM	Meet No/Date:15/82-	Status:
ALC4/2018	PVT.LTD.,	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0510400700	Defer Date:
:01/82/050/01721/AM19/	:05/23/040/00387/AM17/	09.12.2016

	Case No.:264/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/01721/AM19/	RLA File<br>:05/23/040/00387/AM17/	Lic.No/Date:0510400700<br>09.12.2016	<br>Defer Date:

ALC4/2018 22.03.2019|Status: Approved| |---|---|---|---|---| ||HQ File :01/82/050/01721/AM19/|RLA File :05/23/040/00387/AM17/|Lic.No/Date:0510400700 09.12.2016| Defer Date:| |175|**Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: Export Product Qty. Sl.No. Import items Qty. Drug Formulations Injections / Ampules / Vials. Cefuroxime Sodium For Injection 1.5GM. Net Weight: 215.516KG 143678.00 Number 1 Relevant Bulk Drug Cefuroxime Sodium 249.35 kg RA concerned maytake further necessaryaction asper above decision of NC.||||

176	Case No.:266/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,<br>RLA File<br>:05/23/040/00386/AM17/	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019<br>Lic.No/Date:0510400704<br>09.12.2016	Status:<br>Deferred
	HQ File<br>:01/82/050/01723/AM19/			Defer Date:
	Decision:CLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Mumbai.

*Decision:**CLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Mumbai.||||

	Case No.:524/15/82-	Party Name:RELIANCE	Meet No/Date:15/82-	Status:
	ALC4/2018	INDUSTRIES LTD.	ALC4/2018	Deferred
			22.03.2019
177	HQ File	RLA File	Lic.No/Date:0310809723	Defer Date:
	:01/82/050/01981/AM19/	:03/95/040/00027/AM17/	09.12.2016
	Decision:The Committee decided to refer the case to Special Committee for further consideration.

	Case No.:679/15/82-	Party Name:BELOOR BAYIR	Meet No/Date:15/82-	Status:
	ALC4/2018	BIOTECH LTD	ALC4/2018	Deferred
			22.03.2019
178	HQ File	RLA File	Lic.No/Date:0710110770	Defer Date:
	:01/82/050/02136/AM19/	:07/24/040/00273/AM17/	09.12.2016
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Bangalore.

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

	Case No.:271/15/82-		Party Name:ARKRAY		Meet No/Date:15/82-	Status:
	ALC4/2018		HEALTHCARE PVT.LTD.		ALC4/2018	Deferred
					22.03.2019
179	HQ File		RLA File		Lic.No/Date:5210042097	Defer Date:
	:01/82/050/01728/AM19/		:52/24/040/00052/AM17/		14.12.2016
	Decision:RLA, Surat was	requested vide e-mail dated		05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Surat.

Decision: RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Surat.

	Case No.:680/15/82-	Party Name:WINTAC	Meet No/Date:15/82-	Status:
	ALC4/2018	LIMITED,	ALC4/2018	Deferred
			22.03.2019
180	HQ File	RLA File	Lic.No/Date:0710110805	Defer Date:
	:01/82/050/02137/AM19/	:07/24/040/00282/AM17/	16.12.2016
	Decision:RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07
	application of subject Advance Authorization. Application awaited from RLA,Bangalore.

*RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07||||||| |||application of subject Advance Authorization. Application awaited from RLA,Bangalore.|||||||

Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore.

Case No.:1019/15/82-	Party Name:CLARION	Meet No/Date:15/82-	Status:
ALC4/2018	ORGANICS LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:5010002312	Defer Date:
:01/82/050/02476/AM19/	:50/24/040/00013/AM17/	16.12.2016

Export Product	Qty.	Sl.No.	Import items	Qty.
3-HYDROXY<br>ACETOPHENONE (99%<br>ASSY.VALUE)	1 kg	1	ACETOPHENONE (99.50%<br>ASSY.VALUE)	1.61 kg

whichever is lower:

Export Product	Qty.	Sl.No.	Import items	Qty.
3-HYDROXY<br>ACETOPHENONE (99%<br>ASSY.VALUE)	1 kg	1	ACETOPHENONE (99.50%<br>ASSY.VALUE)	1.61 kg

182	Case No.:265/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01722/AM19/	RLA File<br>:08/24/040/00374/AM17/	Lic.No/Date:0810139395<br>28.12.2016	Defer Date:
	Decision:RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA,Ahmedabad.

Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.

Case No.:547/15/82-	Party Name:WINDLAS	Meet No/Date:15/82-	Status:
ALC4/2018	HEALTH CARE PRIVATE	ALC4/2018	Withdrawn
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:6110001392	Defer Date:
:01/82/050/02004/AM19/	:61/24/040/00005/AM17/	02.01.2017

183 Decision: RLA, Dehradun vide letter dated 10.04.2019 has informed that the subject Advance Authorization has already been closed and the firm had deposited Customs Duty + Applicable interest to regularise the case in terms of Para 4.49 of HBP Vol. I (2015-20).

, the Committee decided to withdraw the case.

ready been closed and the firm had deposited Customs Duty + Applicable interest to regularise the case in terms of Para 4.49 of HBP Vol. I (2015-20).

, the Committee decided to withdraw the case.

Case No.:450/15/82-	Party Name:NAARI	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMA PRIVATE	ALC4/2018	Approved
	LIMITED	22.03.2019
HQ File	RLA File	Lic.No/Date:0510401180	Defer Date:
:01/82/050/01907/AM19/	:05/24/040/00486/AM17/	06.01.2017

Export Product	Qty.	Sl.No.	Import items	Qty.<br>204 mg / 200 mg<br>tablet
Mifepristone Tablet 200 MG	1<br>Number	1	Mifepristone

185	Case No.:413/15/82-<br>ALC4/2018	Party Name:SHREE GANESH<br>REMEDIES PVT.LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01870/AM19/	RLA File<br>:34/24/040/00293/AM17/	Lic.No/Date:3410042826<br>10.01.2017	Defer Date:
	Decision:RLA, Vadodrara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA,Vadodara.

*Decision:**RLA, Vadodrara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA,Vadodara.||||

Decision: RLA, Vadodrara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Vadodara.

Case No.:268/15/82-	Party Name:CADILA	Meet No/Date:15/82-	Status:
ALC4/2018	PHARMACEUTICALS LTD.	ALC4/2018	Approved
		22.03.2019
HQ File	RLA File	Lic.No/Date:0810139543	Defer Date:
:01/82/050/01725/AM19/	:08/24/040/00431/AM17/	16.01.2017

	Case No.:268/15/82-<br>ALC4/2018	Party Name:CADILA<br>PHARMACEUTICALS LTD.	Meet No/Date:15/82-<br>ALC4/2018<br>22.03.2019	Status:<br>Approved
	HQ File<br>:01/82/050/01725/AM19/	RLA File<br>:08/24/040/00431/AM17/	Lic.No/Date:0810139543<br>16.01.2017	Defer Date:

ALC4/2018 22.03.2019|Status: Approved| |---|---|---|---|---| ||HQ File :01/82/050/01725/AM19/|RLA File :08/24/040/00431/AM17/|Lic.No/Date:0810139543 16.01.2017|Defer Date:| |186| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: Export Product Qty. Sl.No. Import items Qty. CLARITHROMYCIN TABLETS 250MG ( EACH TABLET CONTAINING CLARITHROMYCIN PH EUR 250MG WITH WASTAGE NORMS RECOMMENDED 255MG) ( NET CONTENT OF CALRITHROMYCIN PH EUR IS 204 KGS) 1 Tablet 1 CLARITHROMYCIN PH EUR ( CLARITHROMYCIN API TO EP8 STANDARED) 255mg/250 mg tablet CLARITHROMYCIN TABLETS 500MG ( EACH TABLET CONTAINING CLARITHROMYCIN PH EUR 500MG WITH WASTAGE NORMS RECOMMENDED 510MG) ( NET CONTENT OF CALRITHROMYCIN PH EUR IS 2907 KGS ) ( THIS LICENSE IS ISSUED IN TERMS OF PARA 4.19 OF FTP AND 4.11 HBP 2015- 2020 NOTATIONAL VALUE OF SUPPLY FREE OF COST INPUT RS. 55649568.00 USD 808860.00) 1 Tablet 1 CLARITHROMYCIN PH EUR ( CLARITHROMYCIN API TO EP8 STANDARED) 510 mg/500 mg tablet RA concerned maytake further necessaryaction asper above decision of NC.||||

1 Tablet 1 CLARITHROMYCIN PH EUR ( CLARITHROMYCIN API TO EP8 STANDARED) 510 mg/500 mg tablet RA concerned maytake further necessaryaction asper above decision of NC.||||

	Case No.:414/15/82-	Party Name:TATVA	Meet No/Date:15/82-	Status:
	ALC4/2018	CHINTAN PHARMA CHEM	ALC4/2018	Deferred
		PVT LTD	22.03.2019
187	HQ File	RLA File	Lic.No/Date:3410042875	Defer Date:
	:01/82/050/01871/AM19/	:34/24/040/00291/AM17/

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 7927 --apply.